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SUMMARY
1) Work in this laboratory has established that there 
exist at least three distinct forms of human placental 
alkaline phosphatase, including two classically described 
soluble forms (A- and B-PLAP), and a membrane form 
specific to the syncytiotrophoblastic microvillous 
membrane, designated M-PLAP.
2) I have extended this work by purifying the three 
isoenzymes of PLAP from placental tissue by developing a 
purification system that exploits their differential 
hydrophobicity.
3) Non-reducing SDS-PAGE was used to resolve the dimers 
of PLAP, which were then visualised either by Coomassie 
Blue or by direct enzyme staining. By this means, I was 
able to confirm the findings of Abu-Hasan and Sutcliffe 
(1985)* namely that M-PLAP runs as a double banded zone 
of activity with a mobility corresponding to a molecular 
size of around 100,000 daltons, while A-PLAP runs with a 
mobility corresponding to a molecular size of around
115.000 daltons. Dimers of B-PLAP were resolved for the 
first time as a single band with a mobility corresponding 
to a molecular size of around 110,000 daltons.
4) Analysis of the subunits on SDS-PAGE has shown that 
a single Coomassie Blue-staining component present in A- 
PLAP is also common to B-PLAP and M-PLAP, suggesting that
all three are composed, at least in part, of monomers of 
similar molecular weights. However, a band of lower 
molecular weight was consistently observed in M-PLAP and 
B-PLAP even when special care was taken to work at 4°C 
and to minimise artifactual proteolytic cleavage. This 
has not been previously reported in PLAP purified from 
the placenta. Independent evidence for the presence of 
another PLAP polypeptide has come from the work of 
Nickson, Livingstone and Sutcliffe (1986), who showed 
that: two PLAP polypeptides (56kD and 58kD) could be
specifically immunoprecipitated from the 'In vitro 
translation of term placental villous mRNA.
5) Unpublished observations by Abu-Hasan and Sutcliffe 
showed that M-PLAP could not be detected in maternal 
serum either by electrophoresis or gel filtration. This 
was intriguing because it was already established (Abu- 
Hasan and Sutcliffe, 1985) that about 95% of the PLAP 
molecule, including its active site, protrudes from the 
surface of the microvillus, and is bathed in maternal 
blood in the intervillus spaces. They suspected that 
serum contained a factor capable of degrading M-PLAP to 
the A- and B-PLAP isoenzymes. The present work has 
confirmed and explained these findings, as follows.
6) Serum can convert M-PLAP to isoenzymes 
indistinguishable from A- and B-PLAP on starch gel 
electrophoresis. These processed PLAP products also have
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dimer* mobilities identical to A- and B-PLAP on non­
reducing SDS gel electrophoresis. It was proposed that a 
factor in normal human serum mediated the conversion of 
M-PLAP to the A- and B-PLAP isoenzymes.
7) This conversion of M-PLAP to the A and B isoenzymes 
can proceed in the presence of protease inhibitors and is 
not accompanied by any change in the subunit size of the 
polypeptide within the resolving limits of reducing SDS 
PAGE. It was therefore concluded that the conversion was 
not proteolytic in nature.
8) I now transferred my efforts to the analysis of the 
conversion factor in .serum. We formed a working 
hypothesis that removal of lipid moieties may be involved 
in the conversion of the hydrophobic M-PLAP to the less 
hydrophobic A- and B-PLAP. Since size fractionation of 
serum indicated that the factor had a size of about 60 
kilodaltons, the serum enzymes lipoprotein lipase and 
lecithin-cholesterol acyltransferase were tested for 
conversion activity, but were found to be ineffective on 
M —PLAP substrate.
9) Attempts to analyse the kinetics of the conversion 
activity were hampered by the lack of a quantitative 
measure of the extent of conversion. Such an assay was 
developed in a model system, in which known ratios of A-,
B- and M-PLAP could be assayed accurately and 
reproducibly. However, for reasons not determined, th^J^
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assay system could not be used to examine the conversion 
status of converted M-PLAP.
10) A purification system was developed for the 
purification of the conversion factor from serum, using 
conventional and FPLC column chromatography. When the 
resultant material was radiolabelled with 125i and 
examined on SDS-PAGE, major components were identified 
with molecular weights of 27.000 and 17,000 daltons.
11) The purified, radiolabelled conversion activity was 
also analysed by 2-dimensional antibody antigen crossed 
electrophoresis (AACE). Precipitin arcs containing 
labelled protein were identified by their relative 
mobilities. These included an arc corresponding to the 
mobility of alpha-lipoprotein, which is comprised of two 
major polypeptide species of 27 and 17kD (apolipoproteins 
A-I and A-II respectively).
12) . Rabbit antiserum raised against human
apolipoproteins A-I and A-II was conjugated onto 
Sepharose and used in the antibody affinity 
chromatography of normal human serum. Depletion of the 
alpha-lipoprotein polypeptides coincided with depletion 
of conversion activity, while the bound and eluted 
fraction was found to contain conversion activity.
13) These results lead us to propose that serum 
apolipoproteins A-I and A-II are associated with the in 
vitro processing of M-PLAP to A- and B-PLAP.
iv
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CHAPTER 1
GENERAL INTRODUCTION
GENERAL INTRODUCTION
This chapter presents a review of the current state 
of knowledge of mammalian alkaline phosphatases, with 
special emphasis on the human placental form of the 
enzyme. Alkaline phosphatases comprise one of the most 
studied groups of all enzymes (see McComb et al, 1979)*
with .different molecular forms having characteristic 
patterns of expression in different species, between 
members of a single species, between tissues of a single 
organism, and within a particular tissue. These 
differences have been identified by a variety of 
physical, structural and functional properties (Fernley, 
1971i Fishman, 197^-). These include molecular and subunit 
properties, electrophoretic, immunochemical, thermal 
stability properties and differential response to 
substrates and effectors of catalytic activity. Much of 
the mechanisms by which such diversity arises is known, 
and will be reviewed below.
The theme of the current researches is human 
placental alkaline phosphatase, which is located on the 
placental syncytiotrophoblast membrane. In order to 
understand the location and possible functional 
significance of this enzyme, it is necessary to quickly 
survey the development, structure and function of the 
human placenta.
1.1 The Human Placenta 
The placenta is an essential, multifunctional,
component of the mammalian reproductive system, whose 
role is to maintain the fetal- environment throughout
gestation. One major function is to transport nutrients, 
water, and gases to the developing fetus and to excrete 
fetal, waste products into the maternal circulation. 
Further, by means of the secretion of hormones, the
placenta is able to modify the maternal metabolism at
various stages of pregnancy. This organ may also be 
involved in the maintenance of the pregnancy as an
allograft, and in the inhibition of the intrinsic 
clotting system, which normally is activated when blood
comes into contact with non-endothelial surfaces.
1.1.1 Human Placental Development
Following implantation of the developing blastocyst 
in the uterine wall, the trophoblast infiltrates the 
endometrial endothelium until, by the ll-12th day, the 
blastocyst is completely embedded. At this stage, the 
trophoblast cells differentiate into cytotrophoblast, 
which becomes less common as the placenta matures, 
surrounded by primitive syncytiotrophoblast. Up to the 
25th day of pregnancy, there is a period of intense 
growth and differentiation as the "fingers” of chorionic
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villi become established. As pregnancy proceeds, the 
villi proliferate and become thinner. Secondary villi
develop from these primary villi which contain various 
cell types and specialised areas. Finally, tertiary villi 
are produced which contain the fetal capillaries.
1.1.2 Placental Microvilli
Mature villi are composed of an outer layer of
syncytiotrophoblast, a layer of cytotrophoblast and an 
inner layer of connective tissue which contains collagen 
fibres, fibroblasts, Hofbauer cells and placental 
capillaries. The syncytiotrophoblast is uniform in
thickness and has a free surface covered by microvilli 
whose cytoplasm is continuous with that of the 
syncytiotrophoblast. These syncytiotrophoblastic
microvilli are suffused on their outer, or maternal, 
side with extra-epithelial blood. Thus, the
syncytiotrophoblast forms the fetal-maternal interface 
across which all exchange takes place. As the fetus 
grows, and its requirements for exchange increase, so the 
syncytium becomes thinner, the microvilli increase in
number, and the placental capillaries move closer to the 
surface. It has been estimated that, at term, the total 
surface area available across which exchange could take 
place exceeds 10m2 (Aherne and Dunnill, 1 96 6).
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1.1.3 Morphology of the Cytotro- and Syncytiotrophoblast
There are considerable morphological differences 
between the syncytiotrophoblastic and cytotrophoblastic 
layers. The cytotrophoblast cells show considerable 
-variation in shape, dependent upon location and gestation 
period. They have little detectable intracellular 
structure, having a scarcity of endoplasmic reticulum and 
organelles (Boyd and Hamilton, 1970). In contrast, the 
syncytium has a high concentration of mitochondria, 
lysosomes, vesicles, vacuoles, microtubules,
microfilaments and endoplasmic reticulum (Wynn, 1975)- 
This structural evidence has led to the hypothesis that 
the syncytiotrophoblast is the major endocrinologically 
active tissue of the placenta.
1. 1. Placental Proteins
Studies of placental brush border protein components 
has been stimulated primarily by the discovery of Smith, 
Brush and Luckett (197^-) that placental preparations 
enriched in microvillous membranes could be obtained by 
differential centrifugation of a saline extract of whole 
placental tissue. Using SDS-PAGE electrophoresis, workers 
have in general found between 16 and 20 polypeptide 
species (Carlson et _al, 1976; Smith et_ al_, 19791 Kelley 
et al , 1979)- Albumin, transferrin and alkaline
phosphatase are major components in all preparations.
Albumin is present as a contaminant and is derived from 
contaminating fetal and maternal blood. Transferrin is 
present in relatively high concentration due to binding 
to the large number of transferrin receptors on the 
membrane (Loh ejt al, 1930). Placental alkaline 
phosphatase is the major external structural protein 
component of the microvilli (Jones and Fox, 1976;
Doellgast and Benirschke, 1979)*
Several - groups have tried to identify further 
placental brush border protein components either by 
analysis of proteins present in microvillous membrane 
preparations, or by cytochemistry. These species can be
classified as binding sites, enzymes and other proteins
(for review, see Truman and Ford, 198£l). Those membrane 
proteins defined as binding sites include specificities 
for immunoglobulin G (Van der Meulen e_t al, 1980; Johnson 
and. Brown, 1 98 1), transferrin (Loh et al, 1980), low 
density lipoproteins (Alsat et al, 1 9 8 2), insulin
(Whitsett and Lessard, 1978) and epidermal growth factor 
(Hock ejt al_, 1979; Ogbimi at al, 1979)* Those enzymes
found in microvillous membrane preparations include 5 f- 
nucleotidase (Truman et al, 1 9 8 1 ) and various ATPases.
Other proteins thought to be specifically synthesised 
during pregnancy, though not exclusively by the 
trophoblast tissues, include the pregnancy associated 
proteins SP1, PP5» and PAPP-A (Sutcliffe et al, 1980;
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Klopper, 1930). A recent review of placental specific 
proteins has been written by major contributors to the 
field, edited by Rosen (1986).
1.1.5 Placental Immunology
A major area of investigation is the mechanisms by 
which the placenta is maintained as an allograft. On an a. 
priori basis, the fetal/placental unit is a "good 
candidate for eliciting a maternal immune response, since 
trophoblast cells are in direct physical contact with 
both the maternal blood supply and the maternal 
endometrium. Indeed, several studies have shown that the 
syncytiotrophoblastic microvilli are sufficiently 
immunogenic when injected into mice to elicit an immune 
response (Beer ejt al, 1972a,b). Maternal lymphocyte 
recognition of paternal determinants on the trophoblast 
surface is an area of contention at present. Whereas 
Davies ejt al (1982a, 1982b) provided evidence of such a
phenomenon, their results remain to be confirmed by other 
workers. Nickson and Sutcliffe (1 9 8 6 ), using a passive 
haemaglutination assay, failed to detect anti-trophoblast 
antibodies in maternal serum. Similarly, recent work by 
Hole ejt al (1987). using an ELISA assay with solubilised 
placental plasma membrane proteins, detected no 
significant difference in titre between pregnancy sera 
and normal male sera. Nevertheless, it is known that the
syncytiotrophoblastic membranes do not express 
histocompatibility antigens, on the basis of a negative 
reaction on immunohistochemistry (Goodfellow et aJL, 1976; 
McIntyre and Faulk, 1979). *
The mechanisms by which the placental allograft is 
maintained is not known, although three possible 
hypotheses have been formulated, none of which are 
mutually exclusive. It is possible that the fibrinoid 
layer at the utero-placental interface may act as a 
physical barrier to maternal lymphocytes or other 
cellular elements (Sutcliffe et .al, 1982). Maternal 
antibodies raised against paternal antigens on the fetal- 
maternal interface may bind and act "block11 the 
sensitised maternal lymphocytes and cellular components 
from reaching their targets. Other blocking factors have 
been described by Rocklin et al (1976). A third 
hypothesis was proposed by Wynn (1975) in which 
trophoblastic exfoliation acts to divert the maternal 
immune system from the conceptus.
It has been proposed that a degree of immune 
recognition is necessary for the maintenance of 
pregnancy. Couples in which the woman has had habitual 
recurrent spontaneous abortions are thought to express a 
greater degree of sharing of HLA determinants than would 
be expected with reference to couples with no such 
history (Beer et al_, 1981). Faulk (1981) proposed that
recognition of the paternally derived TLX specificities 
on the placental surface is necessary for maintenance* 
although these specificities have never been identified 
biochemically. Evidence supporting the hypothesis of 
immune recognition was gleaned by Mowbray et al (1985) 
who found that immunisation of recurrent aborters with 
their partner’s lymphocytes, and hence, hypothetically, 
the _ generation of antibodies against paternal 
determinants, appeared to result in an increase in 
successful pregnancy.
In short, therefore, the syncytiotrophoblastic 
microvilli are important in the transport of nutrients, 
gases and waste material between the maternal and fetal 
blood supplies. The brush border, or its components, may 
have a role to play in making the fetal/placental unit an 
immunologically privileged site. The membranes are also 
instrumental in steroid/hormone signaling between the 
mother and the developing embryo, as well as synthesising 
a number of enzymes and other proteins of unknown 
function. One example of such an enzyme, and a major 
protein of the term syncytiotrophoblastic microvilli, is 
placental alkaline phosphatase.
1.2 Mammalian Alkaline Phosphatases 
Alkaline phosphatases (orthophosphoric-monoester 
phosphohydrolase (alkaline optimum), EC 3* 1.3.1) ar,e> a
group of nonspecific phosphomonoesterases located 
primarily in the plasma membrane of the cells in which 
they occur. In vitro studies of the enzyme has revealed 
that they also exhibit phosphotransferase (Herraez et al , 
1980) and protein phosphatase activities (Swarup et al, 
1981; Lau et al, 1977)- The lack of substrate specificity 
and the broad spectrum of activities exhibited by 
alkaline phosphatases have rendered the elucidation of 
the physiological function of the enzyme difficult.
Alkaline phosphatases are among the most widely 
studied groups of enzymes, and have been found in 
bacteria, plants, and animals (see McComb et al, 1979)* 
In man, they exist as highly glycosylated homodimers, and 
as such are found in essentially all tissues, although 
they have been best studied in those tissues containing 
the greatest activities, namely liver, bone, kidney, 
intestine and placenta. Table 1 presents a number of the 
properties of particular alkaline phosphatase species.
1.2.1 Physiological Function of Alkaline Phosphatases
The functional significance of mammalian alkaline 
phosphatases have yet to be established. Many lines of 
evidence have indicated that there is a correlation 
between alkaline phosphatase and fat absorption and/or 
phosphatidate hydrolysis (Fishman, 197&; Ehle et a l , 
1985; Sumikawa et; al, 1 9 8 7)* Alkaline phosphatases are
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Isoenzyme Tissue Unspecific Tissue Specific
Type L/B/K AP IAP PLAP
Further Loci 
Early IAP PLAP-like
MW (kD) 136-170 lttO-170 116-125 N. D. subunit
Allelic
diversity — — 4-4- 4- — —
Cloned
/Sequenced 4- + 4- - -
pH optima 10. 1 10. 1 10.7 10 . 1 10. 6
Heat Stability:
56°C 15min +/+ + 4- + 4- 4- 4- 4- 4- 4- 4-4-
65°C 5min - - 4-4-4- - 4- 4-4-
Amino acid 
sensitivity (5mM) 
1-phenylalanine 4-4-4- 4-4-4- 4-4- 4- 4-4-4-
1-homoarginine 4- 4- 4- -/+ ~/+ -/+ -/+
1-leucine 4- 4- 4- 4- 4- *+■ 4- 4-4-
Electrophoretic
mobility fast slow intermediate fast intermed,
Sialic acid 4- - 4- *+* 4-
Lectin Binding + - 4-4- 4- 4- 4-
Immunoreactivity 
to antisera to: 
Liver AP 4-4-4-
Bone AP 4- 4-4- - - - -
Kidney AP 4- 4-4- - - -
Intestinal AP - 4- 4-4- 4- 4-4- 4-
Placental AP - 4- 4-4-4- 4- 4- 4-4-
TABLE 1.1. Multiple Forms of Human Alkaline Phosphatase; adapted from 
Stigbrand (1984.).
also thought to be intimately related to mineralisation 
of bone and ossifying growth-plate cartilage (Burch ejt 
a l , 1985)* Alternatively, other workers have proposed
that alkaline phosphatase contributes to the regulation 
of cell growth by selective tyrosyl dephosphorylation 
(Risk and Johnson, 1985). and could hence be important in 
controlling the interaction of cell surface receptors
with (epidermal growth factor and insulin (Avruch et a l , 
1982; Hunter, 1982). Again, initial researches in this 
laboratory, and by Hutton et al (1980), have suggested
that placental alkaline phosphatase is important in the 
inhibition of blood clotting, via the degradation of ADP.
1.2.2 Genetic Diversity in Alkaline Phosphatases
Analysis of the immunological, catalytic and 
electrophoretic properties of the alkaline phosphatases 
extracted from mammalian tissues indicates that there are 
several classes of mammalian alkaline phosphatases, and 
that they are encoded by at least three structural genes 
(Seargeant and Stinson, 1979; McKenna et a l , 1979;
Goldstein et_ al_, 1980a). For a review of multilocus 
enzyme systems as illustrated by mammalian alkaline
phosphatase see Harris (1982).
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1.2.2.1 Tissue unspecific Alkaline Phosphatase (L/B/K A P )
One form of alkaline phosphatase is found
predominantly in osteoblasts, fibroblasts, leukocytes, 
and in cells from a variety of different tissues,
including: liver, kidney, breast and brain- This is known 
as the tissue-unspecific, or liver/bone/kidney form of 
alkaline phosphatase (L/B/K AP). The isoenzymes extracted 
from • these cells and tissues are known to be
immunochemically identical (Boyer, 1963). and are 
similarly sensitive to inhibition by 1-homoarginine
(Fishman and Sie, 1970).
1.2.2.2 Intestinal-type Alkaline Phosphatase (IAP)
Intestinal alkaline phosphatase (IAP) is one example 
of a tissue-specific AP, and as such is largely confined 
to the brush border membranes of the small intestine. It 
can be distinguished from other APs by specific antisera, 
though some cross-reaction with antisera raised against 
placental alkaline phosphatase can be seen. It shares 
several properties with placental alkaline phosphatase in 
that it is partially heat stable, resistant to catalytic 
inhibition with 1-homoarginine, and sensitive to 
inhibition with 1-phenylalanine (Ghosh and Fishman, 
1966). IAP is a glycoprotein, but it does not contain 
sialic acid residues, neither does it bind to 
concanavalin nor lentil lectin (Lehmann, 1 9 8 0 ).
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Studies using monoclonal antibodies, tryptic peptide 
and cyanogen bromide peptide mapping indicates that there 
exists a form of intestinal alkaline phosphatase 
expressed in the fetus up to to 30 weeks gestation, which 
is similar, but not identical to the adult isoenzyme 
(Vockley et al, 1984a; Vockley et al, 1984b). It is
proposed that this is expressed from a further alkaline 
phosphatase gene locus, although some developmentally- 
related difference in gene-rearrangement or messenger- 
processing cannot be excluded.
1.2♦2.3 Placental-type Alkaline Phosphatase (PLAP)
Placental alkaline phosphatase (PLAP) is the other 
major tissue-specific alkaline phosphatase, and is mainly 
confined to the placenta of higher primates including
orangutan, chimpanzee and man (Doellgast, 1984). Although 
catalytically similar to the adult intestinal isoenzyme, 
it can be distinguished with some monoclonal antibodies 
and by its marked heat-stability (Neale et. a l , 1965;
Beratis and Hirschorn, 1972). PLAP is also slightly more 
sensitive to inhibition with 1-leu-gly-gly and 1-phe-gly- 
gly (Doellgast and Meis, 1979).
Alkaline phosphatase activity has been detected in 
the placenta as early as the first 6-10 weeks of
pregnancy. This form of alkaline phosphatase was found to 
consist of two heat sensitive and 1-homoarginine
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inhibitable species, one of which shared antigenic 
determinants with L/B/K AP, the other being antigenically 
unique (Fishman e_t al, 197 6; Sakiyama et al , 1979).
Between the eleventh and thirteenth weeks of pregnancy, 
the expression of AP is in a state of flux, during which 
the early-type, or developmental phase-specific alkaline 
phosphatases are replaced by the classically described 
PLAP. From there, placental alkaline phosphatase serum 
concentrations rise exponentially to a peak level at 
delivery of around 250ng/ml, and clearing from the blood 
within six days of delivery (Holmgren ejt al, 1973).
Heat-stable, 1-homoarginine resistant and 1-
phenylalanine resistant alkaline phosphatases have been 
detected in trace amounts in the normal human testis 
(Chang ejt al , 198O), in lung, cervix, and thymus (Nozawa
et al , 198O j Goldstein e t . al, 1980b; Goldstein e_t al,
1982a), and in intestine and liver (Garattini, et a l ,
1 9 8 5 ). However, these PLAP-like enzymes are also 
sensitive to inhibition with 1-leucine and EDTA, and some
question remains as to whether they represent a further 
AP locus, or whether they are differently processed 
transcripts or polypeptides. This picture is confused by 
the existence of a rare allelic variant of PLAP, namely 
the D- or 18-variant, which is indistinguishable from the 
PLAP-like alkaline phosphatase described above (Doellgast 
and Fishman, 1976).
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1.2.3 Predicted Amino Acid Sequences of Mammalian APs
The cDNA sequence for one form of intestinal AP and 
one form of L /B /K  AP has been cloned and sequenced (Weiss 
et al, 1 9 8 6 ; Henthorn at■ al, 1 9 8 7 ). In addition, Henthorn 
et al (1986) have cloned and sequenced the products of 
two common alleles encoded by the locus for human 
placental alkaline phosphatase, namely type 1 and type 3* 
The amino acid sequence predicted from the cDNA sequence 
of all four is presented in Table 2.
The analysis of Henthorn et al (198 6) identified ten 
single nucleotide substitutions between the two alleles 
of placental alkaline phosphatase, seven of which result 
in a difference in the amino acid sequence presented in 
Table 2. This amount of variation between the two alleles 
is unusual, but may be related to the high degree of 
polymorphism at this locus.
Millan (198 6) was able to Isolate and sequence an 
almost full length clone for type 1 PLAP. However, this 
differed from the type 1 sequence published by Henthorn 
et al (1987) at two nucleotide positions within the 
protein coding region. One of these differences results 
in the substitution of a proline for an arginine at amino 
acid position 209. If these differences exist, then this 
may represent microheterogeneity within the . type 1 
phenotype, a hypothesis supported by monoclonal antibody
111
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Table 1.2. Comparisons of the predicted amino acid 
intestinal alkaline phosphatase (IAP), term placen 
(PLAP1) and known substitutions in the type 3 allel 
liver/bone/kidney AP (L/B/K). Gaps that have been 
maximise pairing of homologous amino acids are indie 
non-conservative substitution of amino acids shown (+ 
interact with the phosphate substrate (*) are also in 
acid +1 corresponds to the first residue in each 
proteins. The sequences are shown in single-lett
corresponds to the amino acids as follows: A, Alanine;
Aspartic acid; E, Glutamic acid; F, Phenylalanine; 
Histidine; I, Isoleucine; K, Lysine; L, Leucine; M,
Asparagine; P, Proline; Q, Glutamine; R, Arginine;
Threonine; V, Valine; W, Tryptophan; Y, Tyrosine.
Adapted from Weiss et al (1 9 8 6 ), Henthorn et al 
et al (1987a).
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studies (Slaughter ejt al, 1933).
Kam et ajL (1935) also published a sequence for human 
placental alkaline phosphatase. However, no attempt was 
made to identify the PLAP morph cloned. On comparison 
with the sequences of Henthorn ejt aJL (1986), the sequence 
of Kam ejt al (1985) differs from the type 1 polypeptide 
by 7 amino acids, and from the type 3 polypeptide at 12 
amino acid positions. In addition, it was unique at two 
silent site nucleotide positions, and at one 3 ’- 
untranslated position. This morph was argued by Henthorn 
et al_ (198 6) as representing one of the many rare alleles 
of PLAP.
1. 2. ll Allelic Diversity in Alkaline Phosphatases
Placental alkaline phosphatase is the only isoenzyme 
of alkaline phosphatase with a well documented 
polymorphism in the true sense of the term. It has long 
been known that placental alkaline phosphatase is 
peculiar in that it is extremely polymorphic (Boyer, 
1961). Three common alleles give rise to six common 
phenotypes, with types 1 , 2 and 3 representing
homozygotes and types 2-1 , 3-1 and 3-2 representing
heterozygotes (Robson and Harris, 1965; Beckman et a l , 
1 9 6 6). In addition, at least 18 rare alleles occur, 
producing rare variant electrophoretic phenotypes, most 
of which comprise a rare allele in combination with one
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of the common alleles (Robson and Harris, 1967; Harris et 
al, 1974). Although individually uncommon, such rare 
variants occur in 3-5% of placentas (Donald and Robson, 
197Z1). in comparison, the average heterozygosity for rare 
alleles at 42 different loci has been estimated as 
occurring in about 0.11% of cases (Harris at al, 1974)• 
The reasons for this high degree of allelic diversity at 
the PLAP locus is not known, and may involve an unusual 
degree of intragenic crossing-over, gene conversion, 
single base mutations, or other phenomena. There are no 
differences between these enzyme variants with respect to 
pH optima, Km values or inhibition with 1-phenylalanine. 
However, variations in thermostability are detected 
(Holmgren and Stigbrand, 1976). Variants can also be 
discriminated by allozyme-absorbed antisera (Wei and 
Doellgast, 1 9 8 0). The structural basis for such 
polymorphism has not been fully elucidated, except in the 
cases of the two common alleles described above.
1.2.5 Evolution of Mammalian Alkaline Phosphatases
The predicted amino acid sequence comparison of the 
alkaline phosphatases shown in Table 2 indicates that 
there exist several areas of conserved amino acid 
sequence, particularly in those regions comprising the 
active site of the enzyme, as identified by binding to 
substrate phosphate. PLAP shows a greater overall amino 
acid homology to IAP (8 6 .5%) than to L/B/K AP (52%) with
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IAP and PLAP sequences showing an approximately equal 
divergence from the tissue-unspecific AP. This is 
consistent with the biochemical and immunological 
characterisation of the AP proteins (Lehmann, 1975; 
Doellgast, 1984). Comparisons of protein and DNA suggest 
that PLAP is the result of a recent duplication of the 
gene for IAP, followed by divergence of both sequences.
PLAP and IAP genes both contain a relatively long 
3 f-untranslated region, which can be used to estimate the 
time in evolution when the gene duplication giving rise 
to placental and intestinal APs occurred. Assuming that 
this region is not under selection, the percentage of 
divergence (26.1%) can be compared to the divergence 
between presumably unselected DNA sequences in other 
pairs of species. Using this method, Henthorn et al 
(1987) estimated that gene duplication took place before 
the divergence of New World monkeys and the lineage that 
gave rise to both the Old World monkeys and the
hominoids, perhaps as early as the time of the divergence 
of prosimians (lemurs, tree shrews, lorises and tarsiers) 
from anthropoids (monkeys and apes). This estimate is
consistent with the finding of PLAP in the placentas of
the great apes but not in the placentas of many other
primate species (Goldstein et a l , 1982b).
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1 . 2 . 6  Post-Translational Modification of Mammalian APs
Differences observed between alkaline phosphatase 
species cannot wholly be attributed to expression of 
alleles from different genetic loci, and much evidence 
has been gathered which shows that differential post- 
transcriptional modification of the mRNA transcript 
and/or of the nascent polypeptide chain takes place.
1. 2 . 6 .‘l Glycosylation of Alkaline Phosphatases
As mentioned above, the isoenzymes of tissue 
unspecific alkaline phosphatase are immunochemically 
identical, and are similarly inhibited by 1-homoarginine. 
However, different electrophoretic patterns are observed 
for these isoenzymes following electrophoresis in agar 
gels (Smith et a l , 1973). and are inactivated at widely 
different rates by urea and temperature (Moss and Whitby, 
1975)* Since treatment of these isoenzymes with 
neuraminidase abolishes these differences, they are 
considered to be largely the result of differences in 
carbohydrate moieties (Stinson and Seargeant, 1981; Moss, 
198^) .
1.2.6♦2 Membrane Binding of Alkaline Phosphatases
Recent results bearing on the mechanisms by which 
alkaline phosphatases may be bound to the cell membrane, 
as well as bearing on the results herein reported, will 
be presented in the general discussion. In short, most
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evidence currently available suggests that at least some 
of the mammalian alkaline phosphatase protein family 
should be regarded as members of a new class of membrane 
proteins. These proteins are bound to the plasma membrane 
through a carboxy-terminal amino acid linkage to 
phosphatidylinositol. The first such protein to be 
discovered and fully characterised was the variant
surface glycoprotein (VSG) of the parasite Trypanosoma 
brucei. This glycoprotein is synthesised with a 
hydrophobic carboxy-terminal domain that is very rapidly 
(within 1 minute) cleaved and replaced by a 
glycophospholdpid, which then anchors the VSG to the 
membrane. An endogenous enzyme with phosphatidylinositol- 
specific phospholipase C activity is then able to 
specifically cleave the surface coat. Whether this 
mechanism is also employed in alkaline phosphatases is 
presently not known, particularly in the case of the
placental isoenzyme, but the hypothesis should be borne 
in mind that post-translational modification may be 
important in generating membrane-bound and soluble forms 
of alkaline phosphatase.
1.2.7 Further Variants of Mammalian APs
As well as the well characterised alkaline 
phosphatases from defined genetic loci and their allelic
variants, there are a number of forms of alkaline
phosphatase whose origins are less well understood.
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1. 2 . 7 . 1 Tumour* Alkaline Phosphatases
In 1968, Fishman ejt alL (a,b) detected an alkaline 
phosphatase isoenzyme in the serum and tumour tissue of a 
patient with bronchogenic carcinoma. On examination, this 
AP had properties identical to those of PLAP. This was 
called the Regan isoenzyme after the patient, and was 
shown to be indistinguishable from PLAP with regard to 
heat stability, inhibition with 1-phenylalanine, optimum 
pH, electrophoretic migration, action of neuraminidase 
and specific reaction with rabbit antisera to PLAP. 
Cleeve and Tua (1983) have since proposed that the Regan 
and PLAP isoenzymes are products of the same structural 
genes.
Another tumour-associated variant of heat-stable
alkaline phosphatase, detected initially by Nakayama et
al (1970), is referred to as the Nagao isoenzyme. This 
has all the properties of the Regan isoenzyme, but is
additionally sensitive to 1-leucine and EDTA. The 
existence of a PLAP-like isoenzyme in tumours was 
confirmed by Inglis et al (1973) who, on examination of 
39 cancer patient sera containing alkaline phosphatase 
activity similar to PLAP, found that approximately half 
of the APs were inhibitable by 1-leucine.
Increased levels or inappropriate expression of PLAP 
or PLAP-like isoenzymes have been associated with a
number of different benign and malignant tumours of
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trophoblastic and non-trophoblastic tissues and organs. 
These include malignancies of the pancreas, lung, breast, 
colon, lymph nodes, kidney,, stomach, and bladder (see 
Higashino ejt al_, 1912.-; Fishman and Stolbach, 1979; 
Stigbrand and Engvall, 1932), although higher levels are 
consistently found in seminomas (Nathanson and Fishman, 
1971; Wahren elfc al, 1979; Jeppsson ett al_, 1934) , and in 
ovarian and uterine cancers (Benham et_ aJL, 1978; Nouwen 
et al,' 1985) •
It remains to be established whether or not there is 
a relationship between the rare 13-, or D-, variant of 
PLAP, the Nagao isoenzyme, and the 1-leucine sensitive 
isoenzyme expressed in trace amounts in normal tissues. 
However, it seems likely that, at least in some cases, 
the transformation of a cell line from normal to 
malignant is associated with the over-expression of the 
PLAP-like enzyme from the same locus (Millan et al_, 1982; 
Mill'an and Stigbrand, 1983)* It is also unknown what 
significance can be placed on the finding of a rare 
allele so commonly expressed in tumours. Does this imply 
that there is a predisposition for cancer among 
individuals of this phenotype; does the variant normally 
arise through aberrant post-transcriptional modification, 
a pathway which is forced in the case of malignant 
tissues; or does tumour expression represent re­
expression from a different gene or pseudogene, whose 
transcript is fortuitously similar to that of a PLAP
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allele?
PLAP or- PLAP-like alkaline phosphatases are not the 
only APs found associated with transformed tissues. A 
tumour enzyme identified in a patient with a hepatoma was 
found to be temperature-sensitive, 1-phenylalanine and 1- 
leucine sensitive, but insensitive to inhibition with 1- 
homoarsinine. Since it also reacted with anti-intestinal 
AP antibodies, this Kasahara variant was seen as a IAP- 
like 'isoenzyme (Warnock and Reisman, 1969; Higashino et 
al , 1975). This variant has also been described in renal
cell carcinomas (Hada et aT, 1978).
1.2.8 Alkaline Phosphatase Components
Starch gel electrophoresis of tissue extracts has 
demonstrated that all APs contain at least two groups of 
components. The most anodal form represents the dimeric 
form of the enzyme and is usually the most abundant. The 
other form moves more slowly and is thought to contain 
higher molecular weight species. In PLAP, these forms are 
designated A-PLAP and B-PLAP respectively (Ghosh and 
Fishman, 1968; Beratis ejfc aJL, 1970). Both forms show the 
same polymorphisms, and possess similar heat stability, 
suggesting that both are comprised,at least in part, of 
the same enzymatic polypeptide. However, further studies 
showed that the forms had different isoelectric points, 
mobilities on acrylamide gels and elution points on ion- 
exchange chromatography, and that B-PLAP had a higher
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native molecular weight of around 200,000 daltons. 
Doellgast et al (1977) found that B-PLAP had a lower 
specific activity than A-PLAP, suggesting that B-PLAP was 
associated with material that did not contribute to the 
enzymatic activity- These results led workers to the 
hypothesis that B-PLAP was associated with hydrophobic 
and basic proteinaceous material, although the exact 
basis for the difference between A- and B-PLAP remains
I
unclear. B-PLAP was thought by Doellgast at al_ (1977) "to 
represent the membrane-bound form of the enzyme.
1.2.9 Microvillous Human Placental Alkaline Phosphatase
Work by the Sutcliffe group demonstrated that, as 
extracted from syncytiotrophoblastic microvilli, there 
existed a third, highly abundant form of AP, named M-PLAP 
(Abu-Hasan, Davies and Sutcliffe, 1984; Abu-Hasan and 
Sutcliffe 1984, 1985). M-PLAP was found to share the same
genetic polymorphism, sensitivity to specific inhibitors, 
and similar kinetic behaviour to A-PLAP, suggesting that 
the same enzymatic polypeptide was involved. Furthermore, 
examination of the properties of M-PLAP by antigenic 
cross-reactivity, heat-stability, CNBr and protease 
cleavage maps, amino terminal amino acid sequencing, and 
subunit molecular weight strongly argued against the 
involvement of two distinct genes for the expression of 
the A and M forms of PLAP.
Despite the structural similarities between A- and
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M-PLAP, the M form had rather different properties. M- 
PLAP required the presence of detergent in order to enter 
and resolve in starch or polyacrylamide gels. This was 
explained by the two findings of the relative 
hydrophobicity of M-PLAP, in as much as it remained bound 
to an alkyl Sepharose column under conditions in which A- 
and B-PLAP were eluted, and of the high molecular weight 
of 725.000 daltons for M-PLAP on size exclusion 
chromatography. Such behaviour argued in favour of M-PLAP 
being a membrane form of the enzyme. Further analysis 
(Abu-Hasan and Sutcliffe, 1935) found that M-PLAP could 
be cleaved from intact microvilli with the protease 
subtilisin, resulting in the liberation of an active 
polypeptide composed of subunits reduced in molecular 
weight by around 2,000 daltons. This corresponded to the 
protease susceptible site found by other workers using 
bromelain (Jemmerson et al, 1984; KotteT and Hanford, 
1980). Amino acid sequencing by Abu-Hasan and Sutcliffe 
(1 9 8 5 ), revealed that cleavage was taking place towards 
the carboxy-terminus, thus indicating that M-PLAP was 
bound to the membrane at its carboxy-terminus. The 
deduction of Abu-Hasan and Sutcliffe (1985) that there 
existed a membrane attachment site at the carboxy- 
terminus of PLAP was supported by the recent analysis of 
PLAP cDNA by Kam ejfc al (1985)* However, it remained to be 
determined whether the predicted hydrophobic amino acid 
sequence is present in the mature polypeptide.
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M-PLAP remained distinct from other forms of PLAP 
under all extraction and storage procedures used, 
including solubilisation with butanol, chloroform- 
methanol, nonidet, Triton X-100, and sodium deoxycholate, 
indicating not only that M-PLAP was not an artifact of 
one particular extraction procedure, but also that A- and 
M-PLAP probably differed by the presence or absence of a 
hydrophobic moiety bound tightly to the molecule.
1.3 Strategy of My Investigations
The aims of my researches have essentially focussed 
on three distinct questions, all of which bear on the
structural relationships between the A, B and M forms of 
human placental alkaline phosphatase.
Several unpublished observations from the Sutcliffe 
group had established that a human serum factor had the 
property of "converting” M-PLAP to forms with the 
electrophoretic mobility of A- and B-PLAP. It was 
therefore important to establish how similar the products 
were to the A- and B-PLAP as extracted from whole 
placental tissue. This would be attempted by purification 
of the isoenzymes by ion-exchange chromatography, and
analysis of the monomer and dimer sizes of A-, B~, M- and
converted M-PLAP on starch and acrylamide gels.
A second approach was to characterise the serum 
factor. The initial study of the conversion factor 
focussed on the question as to whether or not the
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conversion was an enzymatic activity. An attempt at 
generating a quantitative assay for conversion would be 
made in order to accurately determine the effects of 
titration of conversion with time, concentration and 
temperature. A number of putative enzymes would also be 
tested for conversion activity.
The final part of the work was an attempt to purify 
and identify the serum factor. Purification would be done 
largely by conventional column chromatography and Fast 
Protein Liquid Chromatography (FPLC). Identification of 
the factor would involve immunological techniques 
including Western blotting, antibody-antigen crossed 
electrophoresis (AACE) and antibody affinity
chromatography.
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CHAPTER 2
THE PURIFICATION OF THE ISOENZYMES OF 
PLAP FROM THE PLACENTA AND AN ANALYSIS OF
THE PRODUCTS OF CONVERSION OF M-PLAP
CHAPTER 2
The Purification of the Isoenzymes of 
PLAP from the Placenta and an Analysis of 
the Products of Conversion of M-PLAP
2.1 Introduction
This chapter presents the methods used to purify and 
characterise the three isoenzymes of human placental 
alkaline phosphatase, and an initial study of the 
conversion activity of serum. Aims and approaches were as 
follows:
1) To purify the A-, B- and M-PLAP isoenzymes from 
the placenta, to confirm the properties of M and A and to 
investigate the characteristics of B-PLAP.
2) To convert M-PLAP and to compare the products of 
conversion with A- and B-PLAP purified from the placenta.
3) To use the purified M-PLAP as a substrate for 
preliminary investigations into the possible identity of 
the conversion factor.
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2,2 PURIFICATION PROTOCOL AND RESULTS
2.2.1 Purif i cat ion of PLAP isoenzymes
The fractionation of the isoenzymes of PLAP on DEAE- 
Sepharose is shown in Figure 2.1. The ion-exchange was 
carried out in equilibration buffer and hence in the 
presence of 0.5 per cent (v/v) Triton X-100. As the 
concentration of NaCl increased, M-PLAP eluted before A- 
PLAP. B-PLAP eluted as a rather broad peak at an
intermediate mean concentration of NaCl. The fractions 
(numbers 18 to 29) containing M-PLAP and B-PLAP were
pooled and subjected to a further round of ion-exchange
under similar conditions. This resulted in a substantial 
separation of M-PLAP and B-PLAP. Fractions numbered 36 to 
U5 (Figure 2.1) were combined to give a pool of A-PLAP 
and B-PLAP. After dialysis against Tris-succinate buffer, 
the pool was divided in two. Half was re-chromatographed 
by ion-exchange in the presence of Triton X-100 as 
before. As shown in Table 2.1, B-PLAP eluted at around 
0.08 M NaCl as expected, and A-PLAP eluted between 0.06 M 
and 0.11 M NaCl. The other half-pool was applied to a 
DEAE-Sepharose CL-6B column equilibrated with Tris-
succinate buffer and eluted with an increasing salt 
gradient in the absence of Triton X-100. Under these 
conditions, B-PLAP was found to elute over a range of 
NaCl strength similar to that of A-PLAP, between 0.08 M
28
1F rac tio n  N um ber
:ur#- 2 .1 . lon-exchang_______   chromatography of
microvillous membrane alkaline phosphatase in the
presence of 0.5% Triton X-100. DEAE — Sepharose CL— 6 B 
chromatography of alkaline phosphatase extracted with 
butanol from placental microvilli. Enzyme activity (in 
nmoles/min/ml), protein concentration and the
concentrations of NaCl are plotted against fraction 
number. Aliquots of the fractions positive for enzyme 
activity were taken for analysis by starch gel
electrophoresis. Horizontal bars show where the three 
isoenzymes eluted as well as which fractions were pooled 
for further purification.
and 0.11 M.
Table 2.1: Ion-exchange chapacter-istics of A-, B- and M-
PLAP: the range of NaCl concentrations required to elute
PLAP isoenzymes from DEAE-Sepharose at ZJ.°C in the 
presence and absence of Triton X-100. In brackets is
shown the concentration of NaCl in the fraction 
containing the maximum activity of the respective 
isoenzyme.
Triton
Isoenzyme X-100 (%) NaCl (mM)
A-PLAP 0.5 70-110 (100)
0.0 70-110 (1 0 0)
B-PLAP 0.5 60-80 (70)
0.0 80-110 (9 0)
M-PLAP 0.5 30-50 (ao)
0.0 170-190 (180)
* In a buffer of 25mM succinic acid, llmM Tris (pH 7.0).
Fractions from the second rounds of ion-exchange
were selected to provide stocks of A-PLAP, B-PLAP, and M- 
PLAP with essentially no cross-contamination by the other 
PLAP isoenzymes. Typical recoveries from each ion-
exchange were around 60 per cent for both protein and
enzyme activity. Material isolated in the final pool of 
A-PLAP constituted 2.5 per cent activity and 0.05 per 
cent protein of the initial butanol extracts of
microvilli. M- and B-PLAP preparations contained 0.6 per
cent of the starting activity and 0.01 per cent of the
29
starting protein. The major loss in recovery of enzyme 
activity was into fractions containing more than one 
isoenzyme. Purity with respect to isoenzymic activity was 
determined by starch gel electrophoresis. Figure 2.2 
shows the purified pools of A-, B- and M-PLAP together 
with the butanol-extracted microvillous membrane starting 
material as observed on detergent starch gels.
2.2.2 Subunits of PLAP isoenzymes
Figure 2.3 shows the purified pools of A-,B- and M- 
PLAP compared under reducing conditions. The single band 
of about 65,000 mol. wt present in A-PLAP (tracks 1 and
2) is also common to B-PLAP (tracks 3 and 4.) and M-PLAP 
(tracks 5 and 6) preparations, suggesting that all three 
are composed, at least in part, of monomers of similar 
molecular weights. The lower band of mol. wt of 
approximately 63.000 was consistently found in. B- and M- 
PLAP preparations from different placentae (tracks 3. 4,
5' and 6). This 63kD band corresponds in mobility to the 
band generated from PLAP by subtilisin cleavage (compare 
Figure 2.4, tracks 1 and 2, and tracks 4 and 5). as 
reported by Abu-Hasan and Sutcliffe (1935)* To minimise 
artifactual cleavage of PLAP during the preparation, 
syncytiotrophoblast membranes were isolated in the 
presence of 2 mM PMSF and 1.0 mg/ml TAME, and special 
care was taken to keep the material on ice and as cold as
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Figure 2.2. Starch gel analysis of ion-exchange 
fractions. The isoensymic purity of A - ,B- and M-PLAP was 
examined on detergent starch gels following purification 
by ion-exchange from butanol-extracted placental
microvilli (St). The gel was stained for enzyme
activity.
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Figure 2.3. SDS-PAQE analysis of ion-exchange 
fractions. The subunit composition of A-, B- and M-PLAP 
was visualised by protein staining following SDS-PAGE gel 
electrophoresis. Tracks 1 and 2 contain A-PLAP (1.0 ug 
and 0.5 ug respectively); tracks 3 and U contain B-PLAP 
(1.0 ug and 0.5 ug respectively); tracks 5 and 6 contain 
M-PLAP (1.5 ug and 3*00 ug respectively). Molecular 
weight calibration is provided from the standard proteins 
transferrin (37kD) and albumin (66kD) run in the same 
ge 1.
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Figure 2.U . Subtilisin treatment of M- and B-PLAP. 
Subtilisin-treated B-PLAP (track 2) and M-PLAP (track 5) 
were run under reducing conditions- in SDS-PAGE, and 
the gel subsequently stained for protein. Tracks 1 and 3 
contain control B-PLAP, and tracks U and 6 contain 
control M-PLAP. The end track contains marker proteins 
with the molecular weights indicated (transferrin (86kD) 
and albumin (66kD)). Spots mark the positions of 
polypeptide bands in the neighbouring tracks.
possible. However, B-PLAP and M-PLAP still showed a 
double-banded pattern on reducing gels and the same 
pattern of enzymatically active bands as shown in Figure
2.5* On no occasion did the A-PLAP preparation show the
double bands. The band at 67,000 mol. wt in M-PLAP 
(tracks 5 and 6) was identified as serum albumin, with 
which it was found to co-migrate.
Figure 2.5 shows A-, B- and M-PLAP run on SDS-PAGE 
under non-reducing conditions, stained for alkaline 
phosphatase activity, and subsequently counterstained for 
protein with Coomassie blue. A major band of A-PLAP
activity (tracks 1 and 2) was found to migrate with a
mobility corresponding to a mol. wt of around 115.000, 
together with minor zones of activity of faster 
mobilities which were detected when the sample is heavily 
loaded (track 2). B-PLAP showed a corresponding band of 
mobility together with one of slightly faster mobility, 
corresponding to a mol. wt of around 110,000 (tracks 3 
and 4). M-PLAP had a double-banded zone of mobility 
considerably faster than either A- or B-PLAP 
corresponding to a mol. wt of around 100,000- (tracks 5 
and 6), together with a protein band of faster mobility 
which co-migrates with the serum albumin marker in the 
adjacent track.
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Figure 2.5• Non-reduced acrylamide gel analysis of 
ion-exchange fractions fallowing PAGE under non-reducing 
conditions. Enzyme activity of A - ,B- and M-PLAP was 
visualized by enzyme staining, and those bands which 
stained are indicated by spots. The gel was subsequently 
counterstained for protein. Tracks 1 and 2 contain A-PLAP 
(1.0 ug and 2.0 ug respectively); tracks 3 and 1 contain 
B-PLAP (1.5 ug and 0.3 ug respectively); tracks 5 and 6 
contain M-PLAP (0.5 ug and 1.0 ug respectively). Track 7 
contains 1.0 ug of serum albumin. Corresponding molecular 
weights were calculated from standard proteins run in the 
same gel under reducing conditions.
2.2.3 Conversion of M-PLAP to A- and B-PLAP
Figure 2.6 shows the effect on the starch gel 
mobilities of the isoenzymes following incubation of PLAP 
with normal human serum. Tracks 1, 3 and 5. where PLAP
was incubated in the absence of serum, were compared with 
tracks 2, tl and 6, where PLAP was treated with serum. A- 
and B-PLAP showed no change on incubation with serum, but 
M-PLAP showed generation of activities corresponding to 
the mobilities of A- and B-PLAP.
The effect on conversion activity of increasing the 
concentration of serum, increasing the duration of 
incubation (0 to 3 hours) and increasing temperature of 
incubation (U.°C to 37°C) was studied in detergent starch 
gels by comparing aliquots of M-PLAP incubated under a 
variety of conditions. The results are shown in Figure 
2.7. Conversion is greater during incubation with 
undiluted serum than is observed during incubation with a 
tenfold dilution of serum (compare tracks H, 5 and 6 with 
tracks 10, 11 and 12). Secondly, during incubation at l l °C
with 1/10 diluted serum, conversion is more extensive 
after 3 hours than after 1 hour or 10 minutes (tracks 1, 
2 and 3). Thirdly, more conversion activity is detected 
at 37°C than at l l °C (comparing tracks 7, 3 and 9 with
tracks IO, 11 and 12).
The products of conversion of M-PLAP to A-PLAP and 
B-PLAP were analysed on SDS-PAGE. Figure 2.8 (panel 1)
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Figure 2.5. Starch gel electrophoresis of PLAP
incubated with or without serum. Aliquots of A-,B- and M- 
PLAP were incubated either in the presence (even-numbered 
tracks) or absence (odd-numbered tracks) of normal human
ser um for a h 0 c s at 37°C in th Pre sence of prot
inh ibi tors t th en run on st ar c h rr- 1s . Track s 1 and 2
con t ai n A- PL AP. tra cks 3 and a con tai n M -PLAP and trac k s 5
and o co n t ain B- PLAP. The nr.■S=el w as st ained f or en zyme
activity.
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Figure 2.7- Conversion of M-PLAP titrated against 
time, concentration and temperature as visualized by 
enzyme staining on detergent starch gels. Time (T i ). 
Incubations were performed for ten minutes, or for 50 
minutes, or for 180 minutes as indicated below the tracks
a°c or at 37°C as indicated below the tracks.
concentration (D n ) . Incubations were performed
Serum
wi t h
either serum diluted 1/10 (D) or with undiluted serum (U)
as indicated below the tracks.
shows an SDS gel in the absence of reduction in which 
control tracks of A-, M- and B-PLAP (tracks 1, 3 and 5,
respectively), incubated without serum, are compared with 
similar material (tracks 2, ll and 6) incubated in the 
presence of serum and protease inhibitors. A-PLAP shows a 
single major4 band of activity, B-PLAP has a band of 
similar mobility and a band of faster mobility. Neither 
A-PLAP nor B-PLAP are affected by serum. M-PLAP shows two 
major zones of activity of considerably faster mobility 
than that of A- or B-PLAP. However, when treated with 
serum, M-PLAP generated two new zones of activity which 
oo-migrated with the zones for A-PLAP and B-PLAP.
Figure 2.8 (panel 2) shows the same incubations, 
together with molecular weight markers and tracks 
containing semi-purified convertase alone run under 
reducing conditions. There is no observable reduction of 
the monomeric molecular weight of A-, B- or M-PLAP. The 
patterns remain as observed in Figure 2.3*
2.2 .11 Further investigation of the serum factor
Partial characterization and purification of the 
conversion factor was achieved by means of 
chromatographic and physiological criteria. On ion- 
exchange on DEAE-Sepharose CL-6B, the factor eluted as a 
unimodal peak of activity at a salt strength of 0.09 M 
NaCl. A similar elution point has been reported for
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Panel 1 Panel 2
Figure 2.8. Serum-converted products on SDS-PAGE. 
Panel 1_. Control A - , M- and B-PLAP (tracks 1, 3 and 5) and
A - , M- and B-PLAP following incubation with normal serum
in the prese nee of protease inhibitors (tracks 2, U. and
6) were visu ali zed by protein staining on polyacrylamide
gels in the abse nee of reduction. Panel 2. The same
materi al was also run under reducing conditions, and
stained for pro te in . Tracks 3 and L contain A-PLAP,
tracks 5 and 6 con tain M-PLAP and tracks 7 and 8 contain
B-PLAP. Tracks 2 and 9 contain semi-purified convertase 
alone. Tracks 1 and 10 contain serum albumin (66000) and 
transferrin (87000).
lecithin cholesterol acyltransferase (LCAT) toy Chong et 
al (1983)5 tout purified LCAT fractions did not contain 
active converting factor. The factor appears to toe a 
glycoprotein since it binds to a ConA-Sepharose affinity 
column. Treatment of a volunteer (RGS) with 5.000 units 
of intravenous heparin did not result in an increase in 
activity of serum conversion when tested against M-PLAP, 
as might have been expected had lipoprotein lipase been 
the conversion agent (Hahn, 19&3; Korn, 1959)- In three 
independent preparations the conversion activity was 
found in the post-lipoprotein fraction of serum; it was 
therefore not found to toe associated with the lipoprotein 
fractions of serum.
The heat stability of the converting agent(s) was 
investigated by preincubating serum at a range of 
temperatures prior to incubation with M-PLAP for 8h at 
37°C. The proportion of M-PLAP converted to A- and B-PLAP 
was then estimated on detergent starch gels; the results 
are presented in Figure 2.9* Conversion activity is 
present in serum preincubated for 1 hour at U 5 ° C (track 
7), but is much reduced in serum preincubated for 30 min 
at 53°C (track 4).
3&
Figure 2.9- Heat inactivation of the serum factor. 
Serum was preincubated under the following conditions and 
the conversion activity was visualised by enzyme staining 
on detergent starch gels. Serum in tracks 2 to 5 was 
incubated for 1 hour, while serum in tracks 6 to 9 was 
incubated for 30 minutes. Incubation was performed at 
37°C (tracks 2 and 6), at 45°C (tracks 3 and 7), at 53°C 
(tracks 1 and 3), and at 60°C (tracks 5 and 9). Tracks 1 
and 10 contain control M-PLAP.
2.3 DISCUSSION
2.3.1 Structural, analysis
Ion-exchange chromatography has been used to 
fractionate three isoenzymes of human placental alkaline 
phosphatase (PLAP). The method took advantage of the 
differential effect of non-ionic detergent on the elution 
of the B and M isoenzymes from diethylaminoethyl-(DEAE)- 
Sepharose CL-6B. Abu-Hasan and Sutcliffe (1984) proposed 
that this chromatographic effect was due to the binding 
of DEAE-Sepharose CL-6B to a hydrophobic component in M- 
PLAP which is reduced in the presence of Triton X-100. 
The present data show that B-PLAP also has hydrophobic 
properties, a suggestion previously advanced by Doellgast 
et al (1977). However, the shift in the elution point 
caused by the detergent is less for B-PLAP than for M- 
PLAP (Table 1), suggesting that the order of 
hydrophobicity is M-PLAP > B-PLAP > A-PLAP. This order is 
supported by the higher affinity of M-PLAP for alkyl 
agarose (Abu-Hasan and Sutcliffe, 1984) and the finding 
that M-PLAP can only be resolved in starch gels in the 
presence of detergent. Detergent causes B-PLAP to have a 
slightly increased mobility in detergent gels but has no 
effect on the mobility of A-PLAP.
Although there was some contaminating albumin in the 
preparation of M-PLAP (Figure 2.3* tracks 5 and 6), the
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results showed that a major polypeptide of mol. wt 65.000 
is common to all three isoenzymes, as has previously been 
reported (Doellgast et_ al_, 1977; Abu-Hasan, Davies and 
Sutcliffe, 1984; Abu-Hasan and Sutcliffe, 1985). The 
molecular weight estimation of 65,000 is in close 
correspondence with that described by Badger and Sussman 
(1976) and by Holmgren and Stigbrand (1976); the value of 
69,00Q previously reported by the Glasgow group has now 
been revised downwards, although some gel preparations 
still yield a PLAP polypeptide of mobility equal to
69,000 mol. wt. The basis of this variation is still 
unknown, but relates to variation between preparations of 
polyacrylamide gel.
Subtilisin cleavage of PLAP generates a band of very 
similar mobility to the 63.000 mol. wt band reported for 
M- and B-PLAP (Figure 2.4). The characteristics of 
subtilisin-cleaved M-PLAP are a PLAP molecule with a 
native mol. wt of around 130,000 and a mobility on
detergent starch gels of slightly faster than A-PLAP. 
However, we believe that this 6 3 .000 mol. wt band is not 
due to proteolytic activity since the 63.000 mol. wt band 
reported for M- and B-PLAP in this paper is present 
without there being these concomitant changes in the size 
or mobility of M-PLAP. Further, the conditions of
purification at low temperature in the presence of
phenylmethylsulphonyl fluoride (PMSF) and Na-p-tosyl-1-
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arginine ester* (TAME) were designed to counter possible 
protease activity. Also, in our hands, proteases are 
equally efficacious on M- and A-PLAP (Abu-Hasan and 
Sutcliffe, 1985). whereas the 6 3 .000 mol. wt band is not 
found in A-PLAP. Since subtilisin activity does not 
visibly modify the 63.000 mol. wt band (Figure 2 . H - ) , the 
subtilisin site must either be absent, masked by
conformation or carbohydrate, or very close to the 
carboxy terminus of the 6 3 .000 mol. wt polypeptide.
Independent evidence for the presence of another 
PLAP polypeptide has recently come from the work of 
Nickson, Livingstone and Sutcliffe (1986), who found that 
two PLAP polypeptides of mol. wt 56,000 and 58,000 could 
be specifically immunoprecipitated from the in vitro 
translation of term placental villus messenger
ribonucleic acid (mRNA). Similar results have been
reported by Ovitt jet al (1 98 6) who also found that only 
one polypeptide was translated in JEG-3. JAR and BeWo 
choriocarcinoma cell lines, confirming the report of Ito 
and Chou (1983). The differences in mol. wt between the 
polypeptides translated :Ln vitro and i_n vivo argue that 
this heterogeneity is not due to glycosylation or any 
other post-translational process. Instead it indicates a 
heterogeneity of PLAP mRNA which specifies two related 
PLAP polypeptides in the syncytiotrophoblast, but not in 
choriocarcinoma cells.
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2.3.2 Isoenzyme Dimer Comparisons
Non-reducing sodium dodecyl sulphate (SDS) 
polyacrylamide gels were used to resolve the dimers of 
PLAP (Figure 2.5). This is particularly convenient as the 
dimers can be detected by enzymatic staining. M-PLAP 
(tracks 5 and 6) runs as a double-banded zone of activity 
of a, mobility corresponding to a mol. wt of around 
100,000. These properties had previously been observed 
for M-PLAP (Abu-Hasan and Sutcliffe, 1984-). The two 
stained species of mol. wt 100,000 would appear to be 
components of M-PLAP, since the samples analysed were 
essentially free of B- and A-PLAP (Figure 2.2). The 
dimers of B-PLAP are now shown for the first time as a 
single band of mol. wt around 110,000 (tracks 3 and 4), 
whereas A-PLAP runs with a mobility corresponding to a 
mol. wt of around 115,000.
2.3.3 Isoenzyme Conversion
Despite repeated attempts, M-PLAP has never been 
detected in maternal serum (N.S. Abu-Hasan, 1985. 
unpublished). This fact can now be explained by the 
finding of a factor in serum which can convert M-PLAP. It 
also establishes M-PLAP as the membrane form of the 
enzyme, with the previously described A and B forms being 
created by conversion from M-PLAP. The products of
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conversion are indistinguishable from A-PLAP and B-PLAP 
on starch gel electrophoresis (Figure 2.6, tracks 1, 4-
and 5)* Further, the processed products have dimer 
mobilities identical to A- and B-PLAP (Figure 2.8, panel 
1, tracks 1, li and 5). This modification does not appear 
to involve a proteolytic step since there is no change in 
subunit molecular weight (Figure 2.8, panel 2, tracks 5 
and 6), and can proceed in the presence of protease 
inhibitors. Within the limits of sensitivity of the 
starch gel system, the conversion activity appears to 
titrate with time, temperature and concentration (Figure 
2.7), and so may be an enzymatic activity. The factor is 
subject to heat inactivation between &5°C and 53°C 
(Figure 2.9).
We pursued the hypothesis that the removal of lipid 
moieties might be involved in the conversion of M-PLAP to 
the less hydrophobic A and B forms. We used the knowledge 
that heparin displaces lipoprotein lipase (LPL) from 
vascular epithelial surfaces (Hahn, 19^3; Korn, 1959). 
to increase the serum concentration of LPL in a volunteer 
(RGS). Since the subsequent serum was not found to 
contain increased conversion activity, the factor is 
unlikely to be LPL. Nor is it likely to be lecithin 
cholesterol acyltransferase, since purified LCAT 
preparations did not contain conversion activity. These 
conclusions must be treated with caution, since these
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materials were tested under conditions which were optimal
for conversion of M-PLAP by serum.
2.3.4- Molecular Heterogeneities
The original reports that M-PLAP is the major 
component of microvillous PLAP proposed that post- 
translational modification or mRNA heterogeneity could 
account for the heterogeneity of PLAP isoenzymes (Abu- 
Hasan and Sutcliffe, 1 98 5 ). On the basis of the present 
work, and that of Nickson, Livingstone and Sutcliffe 
(1 9 8 6 ) and Ovitt et al (1986) both hypotheses seem to be 
required. A-PLAP and B-PLAP have been shown in this 
chapter to be derived from M-PLAP. This does not occur 
spontaneously in solutions of M-PLAP, but requires a
protein factor found in serum. This conversion is not 
accompanied by polypeptide modifications which are
detectable on reducing SDS-PAGE, though it is detected on 
starch and non-reducing SDS gels. This conversion is 
directional; in our hands the A and B isoenzymes do not 
convert to M-PLAP. The existence of A-and B-PLAP as the 
two conversion products of M-PLAP suggested that M-PLAP 
might not be a simple multimer of homodimers (Abu-Hasan, 
Davies and Sutcliffe, 1984.; Abu-Hasan and Sutcliffe, 
1985). but that some assymmetry or heterogeneity exists 
in M-PLAP to generate both A- and B-PLAP. The evidence 
for the doublet 63,000 and 65,000 mol. wt bands in M- and
B-PLAP have been discussed above. Whether* or* not they 
represent post-transcriptional (mRNA) heterogeneity, the 
presence of the doublets in M- and B-PLAP but not A-PLAP 
indicates that M-PLAP is structurally heterogeneous and 
that when converted to the A- and B-PLAP isoenzymes, the
63,000 mol. wt band is present only in B-PLAP. 
Heterogeneity of M-PLAP in non-denaturing gels has 
previously been reported (Abu-Hasan and Sutcliffe, 198&). 
It is proposed that the polypeptide component represented 
by the 63.000 mol. wt band is important in the formation 
of M- and B-PLAP and may confer hydrophobicity upon them. 
How a polypeptide could confer this property is a matter 
for speculation, but it may force the protein to adopt a 
different tertiary structure in which more hydrophobic 
residue are exposed.
The work presented in this chapter was initially 
reported in modified form by Livingstone et al (1 9 8 7 ).
Hi
CHAPTER 3
AN APPROACH TO A QUANTITATIVE ASSAY FOR CONVERSION
Chapter 3
An Approach to a Quantitative Assay for Conversion
3.llntroduction
The previous chapter included some experiments on 
the heat-stability of the conversion factor and the 
effects of time, concentration and temperature on the 
extent of M-PLAP converted. The precision of these 
studies would have been much improved had there been 
available a quantitative assay for the conversion of M- 
PLAP. The results presented in this chapter describe one
approach to the development of such an assay.
It was a well established observation in Glasgow 
that M-PLAP did not migrate into starch gels during 
electrophoresis in the absence of detergent, but rather 
remained on the filter paper insert at the origin. Under 
the same conditions A- and B-PLAP are not retarded. My
hypothesis was that these properties could be used to
separate M-PLAP from the A and B isoenzymes produced 
during the conversion reaction. If this were so, then the 
alkaline phosphatase activity retained on a filter paper 
insert following electrophoresis would be directly 
related to the proportion of M-PLAP present. Performing 
this assay before and after incubation with serum or
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ser-um proteins, by subtraction it would be possible to 
determine the level of conversion that had taken place 
during incubation.
3»1.1 Basic Procedure
M-PLAP stock was incubated with an equal volume of 
serum proteins and lOul aliquots were spotted onto filter 
paper .inserts and electrophoresed at 20V/cm for one hour 
at 1°C in a standard detergent-free starch gel. After 
this time, the filter was removed and placed in 200ul of 
an appropriate detergent solution and incubated at 37°C 
for one hour with frequent vortexing. Aliquots of 20ul 
were removed and assayed in the standard alkaline 
phosphatase assay for one hour at room temperature. This 
was compared with a control of the same sample spotted, 
washed and assayed in the absence of electrophoresis.
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3.2 Results
3» 2.1 Detergent Effects
The initial experiments were aimed at finding 
suitable detergent solutions in which alkaline 
phosphatase activity could be assayed. To this end,
aliquots of M-PLAP were incubated at 37°C for up to one
hour in tris-succinate buffer (pH 7•4) alone, or in
buffer containing one of the following detergentsO.5% 
(v/v) Triton X-100, 0.5% (w/v) sodium, deoxycholate, 0.5%
(v/V) Nonidet NP&O, 0.25% (w/v) sodium dodecyl sulphate, 
or 0.5% (v/v) Tween 20. The mean of triplicate
experiments was calculated and is shown in Table 3.1
presented as a percentage of the control AP activity in 
buffer .alone.
Ilk
Table 3»1: The effect of detergent on M-PLAP
activity in solution following incubation for 30 minutes 
or for 60 minutes.
Incubation
Conditions 30 minutes 60 minutes
Buffer alone 100% 100% 
lit 9% 
271% 
220%
Triton X-100 (0.5%)
Na Deoxycholate (0.5%) 
Nonidet NP40 (0.5%)
SDS (0.25%)
Tween 20 (0.5%)
211%
129%
168%
28% 23%
225%
The above results show that incubation with four of
the five detergents results in an increase in alkaline 
phosphatase activity. No alkaline phosphatase activity 
was detected in these detergent buffer solutions before 
addition of M-PLAP. Neither did the presence of detergent 
have an effect on the extinction coefficient of p- 
nitrophenol at 400 nm. The reason for this "detergent 
effect" was not determined but may be related to the 
relative hydrophobicity of the M-PLAP molecule. Detergent 
may allow a more efficient interaction with the aqueous 
phase and hence with substrate molecules. Having observed 
this effect we were able to allow for it in subsequent 
experiments.
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3-2.2 Recovery of Activity from Filter Paper Inserts
To quantify the alkaline phosphatase activity 
retained on a filter paper insert following 
electrophoresis, it was important that the retained 
activity be efficiently recovered from the insert into 
the detergent wash. To examine the efficiency of a range 
of detergent washes, at the concentrations used in Figure 
3.1. aliquots of M-PLAP were applied to filter paper 
inserts which were then dipped in the appropriate 
solution. This was compared with the addition of M-PLAP 
directly to the appropriate detergent wash (as a 
control). The detergent wash was performed for one hour 
at 37°C with frequent vortexing. Triplicate results are 
presented in Table 3-2.
U6
Table 3.2: The efficiency of detergent solutions in
washing M-PLAP from filter paper inserts.
Incubation 
Conditions
Measured
Activities
Mean Detergent Recovered 
Activity Effect Activity
Buffer
Control
4-
0. 26a 
0. 05a
0.3a8 
0.050
0. 296 
0. 036
0. 303 
0. oa7
100%
15%
NP40
4-
0. ais 
0. 324^
0. 476 
0.339
0. a2a 
0.318
0.1139 
0.327
145%
74%
Deoxy
4-
0. 567 
0. a86
0.575 
0 . 5^8
0.617 
0. a95
0 . 586 
0 . 510
194%
87%
TxlOO
4-
0. a3a 
0. 3a5
0 . 458 
0.296
0. a n  
0. 352
0 . 435 
0 . 331
143%
76%
SDS
4-
0. 055 
0. oa3
0. 068 
0. 02a
0. 030 
0.032
0. 051
0 . 033
17%
65%
Tween
4-
0. ai2 
0.289
0. a33 
0 . 310
0. a39 
0.269
0 . 428 
0.290
iai%
68%
Alkaline phosphatase solution added directly to 
detergent wash ie. no filter paper inserts used. The data 
under the heading "Detergent Effect" was calculated by:
Perc Mean activity in test solution „ 10 entage = M£an"actlvlty In-5n??er-c5ntr5lx ~T
0
+ Filter paper inserts impregnated with alkaline 
phosphatase solution then washed in detergent. The data 
under the heading "Recovered Activity" was calculated by:
Perc Mean activity washed into solution „ 100 entage =  Mean“activity“aaaea~airec:5Iy x "I”
The results of this experiment show that 87% of the 
applied activity is washed from the filter in sodium 
deoxycholate buffer after one hour, compared with 15% for 
the buffer control. It was decided to use this detergent 
routinely in the convertase assay.
4-7
3*2.3 Concentpation of Na Deoxycholate
Up to this stage in the investigation, detergents 
had been used at arbitrarily assigned concentrations. It 
was therefore decided to examine more closely the optimal 
concentration of Na Deoxycholate to use in the assay. 
Table 3.3 shows the results of washing the filter papers 
in one of five different concentrations. Controls were 
the aliquot of M-PLAP added directly into the detergent 
solutions, and the filters washed in buffer alone. 
Triplicate experiments were incubated at 37°C for one 
hour with frequent vortexing.
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Table3♦3 i The efficiency of a range of
concentrations of Na Deoxycholate in washing M-PLAP from 
filter paper inserts.
Incubation Measured Mean Detergent Recovered
Conditions Activities Activity Effect Activity
Buffer
Control 0.199 
0 . 036 0 
0
0
 ro
 
ro
ro 0.192 
0 . 013
0 .20a 
0 . 02a
100%
12%
0 . 05%
+
0 . 291 
0 . 059
0 . 308 
0. 068
0 . 305 
0 . oaa
0 . 301 
0 . 058
ia8%
19%
0.16% 0.3 45 
0 . 093
0 . 36a 
0. 095
0.367 
0.071
0 . 359 
0. 086
176%
25%
0 . 50%
+
0. 394 
0 . 301
0 . aoa 
0.325
0 . a22 
0. 388
0 . ao7
0. 338
200%
83%
1. 10% 0 . 3117
0 . 377
0. 399 
0 . 332
0 . aoo 
0 .338
0.382 
0 . 3a9
187%
91%
2. 50% - 0 . 323 0 . 3aa 0 . 316 0 . 328 161%
+ 0.319 0.332 0.308 .0.320 98%
Alkaline phosphatase solution added directly to 
detergent wash ie. no filter paper inserts. For detergent 
effect:
Percentage = ]p^D_activity in test solution 100 rercen^age Mean activity in Buffer control-' 1
+ Filter paper inserts impregnated with alkaline 
phosphatase solution then washed in detergent. For 
recovered activity:
Percentage = ivity washed into solution 100
reic.eriiabe Mean aciiviiy added directly 1
The results of this experiment demonstrate that the 
earlier fortuitous choice of 0.5/° sodium deoxycholate was 
a good one, since lower concentrations are not as 
efficient in leaching the activity into the wash 
solution. At higher concentrations, the detergent effect 
is not as marked, possibly indicating denaturation of the
alkaline phosphatase.
3» 2.a Conversion Assay Sensitivity to A - , B- and M-PLAP
The next important step in the testing of this assay 
system was to investigate whether there were any 
differences in the recoverable activities following
electrophoresis for A-, B- and M-PLAP. In short, whether 
the assay can discriminate between M-PLAP and A- or B- 
PLAP. For this and subsequent experiments the AP was
taken from the purified isoenzyme stocks shown in the
previous chapter (Figure 2.2). Each stock contained a 
separate PLAP isoenzyme, but they contained differing 
amounts of contaminating protein (Figure 2.3). Thus, in 
order to load filter paper inserts with an equivalent
alkaline phosphatase activity, it would be necessary to 
load differing amounts of protein. It was necessary to 
investigate the effects of different protein loadings 
simultaneously to loadings of A-, B- and M-PLAP. In 
short, this experiment involved loading an equivalent
activity of A- , B- and M-PLAP in either buffer alone, or 
buffer and dialysed bovine serum albumin (Zlmg/ml) 
(dialysed to exclude possible salt effects) . No alkaline 
phosphatase activity was detected in this BSA solution. 
Results are presented in Table 3 - with triplicate
filter paper inserts subjected to electrophoresis at 
20V/cm for one hour at H° C, then incubated at 37°C in
0.5% Na Deoxycholate for one hour with frequent 
vortexing. These are compared to washed filter papers
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that have not been subjected to electrophoresis.
Table 3•1: The sens itivity of the conversion ass,
to A- , B- and .M-PLAP in the pre sence and absence
ilmg/ml BSA.
Incubation
Conditions
Measured
Activities
Mean
Activity
Recovered
Activity
A-PLAP
•+
0 . 150 
0. 033
0. 153 
0 . 039
0 . 168 
0.030
0.158 
0. 035 22?o
B-PLAP
+
0 . 274- 
0 . 101
0 . 286 
0 . 087
0.289 
0 . 106
0 . 281 
0 . 099 35%
M-PLAP
+
o. zt3a 
o. 253
0. 355 
0 . 201
0.368 
O. 239
o. 386 
0.233 60%
A+BSA
+
0 . 107 
0 . 011
0 . 105 
0 . 002
0 . 366 
0 . 003
0. 393 
0 . 006 2%
B + BSA 0 . 70S 
0 . 032
0 . 706 
0 . 013
0 . 683 
0 . 021
0 . 700 
0 . 034 5%
M+BSA
+
0. 507 
0.210
0. 570 
0 . 227
0. 533 
0 . 218
0.537 
0 . 239 16%
- No electrophoresis performed.
+ Electrophoresis performed.
Percentage = Mean_Activity After_Electrophoresis_ 100 
Mean Activity Before Electrophoresis 1
The results show that considerably more AP activity 
remains on the filter paper following electrophoresis 
when applied in the form of M-PLAP than either A- or B- 
PLAP. I interpret this to be because the A and B 
isoenzymes are electrophoresed into the gel. Thus the 
assay is substantially specific for M-PLAP compared to A- 
or B-PLAP. The recovery for B-PLAP is higher than for A- 
PLAP. This may be because B-PLAP has a slower mobility 
than A-PLAP. Thus, more B-PLAP may have left the filter 
paper had the electrophoresis been prolonged. However,
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since 95% of the applied B-PLAP left the paper* in one 
hour, this possibility was not further investigated.
Wash solutions contained more AP activity following 
incubation in the presence of BSA compared to incubations 
in the absence of added protein ( A-PLAP activity 
increases from 0.158 to 0.393; B-PLAP rises from 0.281 to 
0.700; M-PLAP is increased from 0.386 to 0.537). The 
reason for this effect is not known, but may be due to 
alkaline phosphatase binding non-specifically and 
irreversibly to the filter papers, an effect saturated 
out by the added BSA. The results are further complicated 
by the observation that the mean A- and B-PLAP activity 
following electrophoresis was greater in the absence than 
in the presence of BSA (A-PLAP activity dropped from 
0.035 to 0.006, while B-PLAP activity fell from 0.099 to 
0.031). This may indicate the existence of further 
protein-binding sites on the filters which retain protein 
during electrophoresis but release it during the 
detergent wash. Thus, in the absence of BSA, AP binds to 
these sites and subsequently give an increase in the 
overall recovered activity. It is of interest that this 
effect is not observed for M-PLAP.
In short, these effects indicated that this assay 
would be potentially limited to comparing samples at the 
same protein concentration. We termed this limitation as 
being due to the "protein effect".
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3-2.5 Reconstruction Experiment
A final test of the assay was performed using
mixtures of M - , A- and B-PLAP to simulate the end 
products of a range of levels of conversion. No
conversion (0%) was simulated by applying activity in the 
form of M-PLAP alone. Total conversion (100%) was
simulated by applying no M-PLAP, but rather 50% A-PLAP 
and 50% B-PLAP. Intermediate extents of conversion (35% 
and 70%) were also reconstructed with appropriate
mixtures of the three isoenzymes. Since we had
established a "protein effect", and since we hoped to be 
able to use the assay to determine conversion activity in 
serum protein fractions, the assays were performed in 
either 5mg/ml, 20mg/ml or 30mg/ml BSA.
Appropriate mixtures of A - , B— and M-PLAP and BSA
were loaded onto filter paper inserts and subjected to
electrophoresis. The papers were then placed in 0.5%
sodium deoxycholate and washed at 37°C for one hour with 
frequent vortexing. Results were then compared to the 
control, for which activity was detected when an aliquot 
of each mixture was added directly to the detergent wash 
(Table 3*5). Activity was added directly in this control 
to eliminate possible artifacts due to the differential 
binding to the filter paper identified as the "protein 
effect" above.
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Table 3.5: Reconstruction of degrees of conversion 
of M-PLAP to A- and B-PLAP.
Conversion Measured Mean Recovered
Simulated Activities Activities Activity (%)
In 5mg/ml :BSA:
1 + 
0
0. 524 
0 . 242
0. 532 
0 . 224
0. 564
0 . 293
0. 540 
0.253 47%
35% - 
+
0. 674 
0. 145
0 . 697 
0 .13s
0. 640
0.133
0 . 671 
0.139 21%
70% - 0 . 785 
0 . 099
0 . 767 
0.083
0. 74 4 
0. 081
O .766 
0. OSS 11%
100% - 
•t-
0. 862 
0. 048
0. 811 
0. 026
0. 846 
0. 043
0. 840 
0.039 c 0/
In 20mg/ml BSA:
0% - 
+
0. 532 
0. 133
0 . 498 
0.096
0 . 529
0. 148
0.520
0.126 2 4%
35% - 
+
0. 611 
0. 114
0. 555 
0 . 066
0.642
0.129
0 . 603
0.103 17%
70% - 
+
0. 715 
0 . 080
0 . 732 
0 . 053
0. 643
0 . 053
0 . 699 
0 . 071 10%
100% - 
+
0. 362
0 . 036
0. 826 
0. 027
0. 3l6 
0 . 030
0.834
0.031 4%
In 30mg/ml BSA:
1 + 
0
0 . 510 
0 . 078
0 . 491 
0. 133
0 . 515 
0.155
0 . 506 
0.122 24%
35% -*4-
0. 579
0.103
0. 599
0.105
0. 648 
0. 134
0.609
0.114 19%
.70% - 0. 764 
0. 084
0. 841
0 . 063
0.802 
0. 080
0.803 
0.076 9%
100% - 
+
0 . 870 
0. 042
0. 854 
0 . 032
0. 875 
0 . 037
0 . 867
0 . 037 4%
- Alkaline phosphata:se added directly to detergent
solution.
+ Filter papers subjected to electrophoresis, then 
placed in detergent solution.
These results indicate that at each protein 
concentration, the percentage activity recovered in the 
detergent wash was proportional to the amount of M-PLAP
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applied to the filter, and hence proportional to the 
extent of conversion simulated.
3.2.6 Use of the Assay to Monitor Conversion of M-PLAP
At this stage it was decided to use the assay system 
to monitor actual conversion of M-PLAP under the normal 
conditions reported in Chapter 2. However, the PLAP 
material used routinely in the filter paper assay was too 
dilute for me to be able to independently monitor the 
conversion in the PLAP material by electrophoresis into 
detergent gels and subsequent staining ( as described in 
Chapter 2). For this reason, it was necessary to perform 
the conversion reaction with undiluted M-PLAP, after
which a 20ul aliquot was removed and assayed by
electrophoresis and staining. The incubated material was 
then diluted into the appropriate range for the filter 
paper assay.
A second modification was aimed at eliminating the 
"protein effect” . Incubations were performed in either 
undiluted serum or in serum diluted 1/10 or in no serum. 
Overall protein concentrations were standardised by 
making up any shortfall with heat-inactivated serum
(incubated at 53°C for 60 minutes. These conditions had 
previously been shown to remove conversion activity from 
serum (see Figure 2.9))*
In this experiment, M-PLAP was incubated with an
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equal volume of buffer or serum proteins for zero, four 
or sixteen hours. An aliquot was removed and assayed for 
conversion by electrophoresis .. and staining, and the 
remaining solution diluted 1/25- Aliquots of this 
material was spotted onto filter papers and subjected to 
electrophoresis in a detergent-free starch gel at ll°C  for 
one hour. Alkaline phosphatase activity was then washed 
from the filters in 0 . 5 %  sodium deoxycholate buffer at 
37°C in one hour. Activity in the wash solution was then 
assayed, and compared with activity detected when an 
aliquot of each AP solution was added directly to the 
wash solution (Table 3*6).
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Table3•6: Final experimental system. Assay of AP
activity following incubation of M-PLAP with serum 
proteins.
Incubation Conversion Measured Mean Recovered
Conditions Status Activities Activities Activity (%)
zero time: 
zero S
+
- o. 527 
0. 172
0. 500 
0 . 23^
0. 112 
0. 210
0.190 
0. 206 4 2 °o
1/10 S
•+-.
- 0.551 
0.116
0. 570 
0. 250
0. 521 
0 . 231
0.548
0.211 39%
1/1 S
+
- 0. 181 
0. 186
0. 511 
0. 211
0. 541 
0. 151
0 . 513 
0.183 36%
Four hours 
zer o .S
+
- 0. 198 
0. 123
0. 199 
0. 157
0. 459 
0. 167
0.486
0.150 31%
1/10 S
4-
- 0. 516 
0. 150
0. 569 
0. 232
0. 497 
0. 203
0. 538
0.196 36%
1/1 S
4-
4- 0. 180 
0. 161
0. 501 
0. 219
0. 497 
0. 199
0.493 
0. 195 40%
16 hours: 
zero S
4-
- 0.501 
0. 109
0. 515 
0. 107
0. 477 
0. 156
0.493
0.125 25%
1/10 S
4-
4- 0. 517 
0. 199
0. 581 
0. 206
0. 563 
0.196
0 . 565 
0. 201 36%
1/1 S
4-
4- 0. 516 
0. 118
0. 537 
0. 199
0. 463 
0. 180
0 . 506 
0.176 35%
- Alkaline phosphatase added directly to detergent 
solution.
+■ Filter papers subjected to electrophoresis, then 
placed in detergent solution.
* Conversion Status as assessed by electrophoresis in 
detergent starch gels and staining.
These results were expected to show a decreasing
recovery of AP activity with increasing serum
concentration and increasing time. In particular,
material demonstrated to contain conversion activity, and 
hence alkaline phosphatase activity in the form of A- and 
B-PLAP, as well as M-PLAP, were expected to have a
57
corresponding decrease in the recovery of AP activity 
from the filter papers.In reality, no trends were 
observed.
Despite being sensitive to M-PLAP and linear in 
reconstitution experiments, the assay, in its present 
form, could not be used in a real situation.
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Discussion
These experiments set out to design and develop a 
quantitative assay for the conversion of M-PLAP to A- and 
B-PLAP. Such an assay could be used to examine possible 
enzymatic activities of the conversion phenomenon. 
Furthermore, the assay could be used to monitor the
purification of the conversion factor from serum, and to 
provide data on yields of the factor and relative
purification.
The assay is based on the observation that M-PLAP 
was retained at the origin in starch gel electrophoresis 
in the absence of detergent. In contrast, A- and B-PLAP 
migrates into the gel. Subsequent leaching of AP activity 
from the filter paper insert in detergent would allow the 
determination of AP activity retained on the filter
following electrophoresis.
During the pilot experiments, it was jdemonstrated 
that the assay was considerably more sensitive to M-PLAP 
than to A— or B-PLAP (Table 3*4). Furthermore, the 
activity recovered from a filter paper insert was shown 
to be proportional to the relative proportion of M —PLAP 
in a mixture of PLAP isoenzymes (Table 3-5)- However, 
when tested on conversion products, no proportionality or 
linearity was detected between the amount of conversion 
that had taken place (as assessed by electrophoresis and
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staining) and the recovered AP activity. Indeed, no 
significant difference was detected between the 
experimental and control incubations.
We are unable to resolve the conflict between the 
model and final experimental systems. The model system 
worked, whilst the experimental system failed. It is not 
possible to be sure why the assay did not perform as 
hoped, however it was evident from the pilot experiments 
(Table 3«&) that protein concentration affected elution 
from filter papers. It may be possible that the mixture 
of proteins presented in serum (Table 3*6) affects 
elution in a different manner to the BSA present in the 
model system (Table 3-5)* It would have been informative 
to have repeated the reconstruction experiments using 
heat-inactivated serum as carrier, though this in itself 
would not have affected the data in Table 3*6.
Due to the failure of the experimental system, it 
was clear that much additional work would have been 
necessary to develop a quantitative assay. Time did not 
permit these experiments to be done, and work proceeded 
to the purification of the conversion factor using the 
qualitative assay of electrophoresis and staining.
As this research came to a close, Malik and Low 
(1986) published a method for the discrimination of 
hydrophobic and hydrophilic alkaline phosphatases. This 
procedure is a modification of Bordier (1981) and
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involves the phase separation of hydrophobic AP into 
Triton X-11& out of an aqueous mixture of hydrophobic and 
hydrophilic species.
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CHAPTER 4
PURIFICATION AND IDENTIFICATION OF THE CONVERSION FACTOR
Chapter
Purification and Identification of the Conversion Factor
l l. 1 Introduction
The work presented in Chapter 2 amply supports the
hypothesis that M-PLAP is converted to A- and B-PLAP by a
factor present in normal human serum. I now proceeded to
devise a purification scheme for the isolation and
identification of this factor. There being no
quantitative assay for conversion, the purification of
the conversion factor was detected by by gel
electrophoresis as described in Chapter 2.
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a.2 PURIFICATION PROTOCOL AND RESULTS
a .2.1 Purification of Conversion Factor
Ion-exchange chromatography of 50*nl of fresh whole 
human serum was performed on DEAE-Sepharose CL-6B using a 
salt concentration gradient of 0.0-0.15M NaCl, and 155 
fractions of 11ml were collected. Conversion activity was 
detected in a single peak of elution between 0.09M and 
O.iaM NaCl (fractions ll8-12a), with the peak 
corresponding to 0.09M NaCl (fraction 118). Selected 
fractions were resolved on a 10% acrylamide SDS-PAGE gel 
(Figure H. 1) . Two species were detected that did not bind 
to the column at 0.0M NaCl, and these had the approximate 
molecular weights of immunoglobulin heavy and light 
chains (track 5)-
Fractions 113-122 containing the peak of conversion 
activity were pooled, dialysed against tris-succinate 
buffer (pH 7.0), concentrated by freeze-drying and 
applied to a gel filtration column of Sephadex G200. 
Fractions from this chromatography system were collected 
and run on SDS-PAGE together with the pooled fractions 
from the ion-exchange fractionation. The pattern of 
polypeptides eluting from G200 can be seen in Figure l l . 2 
and conversion activity eluted as a single peak in 
fractions 19-21. The major polypeptides corresponding to 
serum albumin peaked in fractions 16-22, indicating that
63
67.
45-
M ■
» *
29-.
*
St St St U 106 114 118 122 „ 126 130 134
tlO  116 120 124 128 132
' . +  + + +
J----- 1
Figure 1.1. SDS-PAGE (10% acrylamide) analysis of 
normal human serum fractionated on DEAE-Sepharose CL-6S. 
The gel was stained for protein. Tracks contain 
unfractionated serum (St), or unbound protein (U), or 
selected fractions (as numbered). Fractions positive for 
conversion activity (+) which were selected for further 
fractionation are indicated by the heavy bar below the 
tracks. Molecular weight calibration is provided from 
standard proteins (albumin, ovalbumin, and carbonic 
anhydr-9.se) run in the same gel.
f
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Figure 
selected 
fractionated 
was stained
exchange fractions (St), or selected gel filtration 
fractions (as numbered). Fractions positive for 
conversion activity (+) which were selected for further 
fractionation are indicated by the heavy bar below the 
tracks. Molecular weight calibration is shown to the left 
of the gel, and was generated using the standard proteins 
albumin, ovalbumin, carbonic anhydrase and trypsinogen.
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the conversion activity has a slightly lower molecular 
weight in the region of 60,000 daltons.
Fractions 19-21 were pooled, filtered at 0.2um and 
applied to an ion-exchange column of Mono Q for FPLC 
(Fast Protein Liquid Chromatography). The column was then 
developed with an increasing salt gradient of between 0.0M 
and 0. tXM NaCl; 5ml fractions were collected. Conversion 
activity was detected as a single peak in fractions 20- 
24, corresponding to a salt concentration of 0.19-0.26M 
NaCl. The polypeptide patterns in these fractions can be 
seen in Figure 4. 3 as resolved by SDS-PAGE (10%
acrylamide). The major polypeptide species present in the 
fractions positive for conversion activity has the
approximate molecular weight of 27kD; minor species can 
also be seen corresponding to albumin and transferrin.
Fractions 20-24- from the FPLC ion-exchange were 
pooled, filtered at 0.2um, brought to a final 
concentration of_1.0M (NH^)2SO^ and applied to an FPLC 
Phenyl-Superose column for hydrophobic interaction 
chromatography. The salt concentration was rapidly 
reduced to 0.2M, then a shallow salt gradient was
produced from 0.2-0.0M salt. Conversion activity was 
detected as a single peak in fractions 20-23*
corresponding to 0.0M (NH^^SOj].. Elution of protein was 
analysed by on-line detection at 280nm, and part of the 
trace is shown in Figure 4.. 4.. Selected fractions were
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Figure U . l±. Elution profile of selected pooled FPLC 
ion-exchange fractions further fractionated by FPLC 
hydrophobic interaction chromatography on Phenyl- 
Superose. Optical density at 2S0nm and concentration of 
(NFOgSO^ are plotted against fraction number. The 
horizontal bar represents elution of conversion activity, 
and those fractions pooled for further fractionation.
resolved on a 12.5°° acrylamide gel under reducing and 
non-reducing conditions (Figure 4-5)* A 27KD band 
comprised about 90% of the Coomassie-Blue stainable 
components under reducing and non-reducing conditions. In 
addition to this major component, there was a species 
present in the non-reduced panel having a mobility
corresponding to a molecular weight of l8kD. Faint bands 
were observed higher up the gel under both conditions, 
and these had the expected mobilities of albumin and 
transferrin.
Table 4.1 shows the results of the overall
purification scheme. The table presents amounts of 
protein applied to the column, total protein recovery
presented both as an absolute amount and as a percentage 
of that applied, and protein present in fractions 
containing conversion activity presented as absolute 
amount and as a percentage of total recovered protein. No 
figures can be given for total protein recovery from the 
FPLC columns, as protein determinations were only made 
for those fractions containing conversion activity.
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Figure ll. 5 ■ Resolution of the polypeptide
components of FPLC hydrophobic interaction chromatography 
fractions containing conversion activity (PSCA) on 12.5% 
acrylamide gel electrophoresis under reducing and non­
reducing conditions, stained for protein. Tracks contain 
molecular weight markers (Mw), pooled FPLC ion-exchange 
fractions (St), selected fractions (as indicated), or
bovine albumin (B). Tracks were run under reducing 
conditions (R) or non-reducing conditions (N). Molecular
weight calibration is shown to the left of the gel, and 
was generated by running the following standard proteins: 
transferrin, albumin, ovalbumin, carbonic anhydrase, 
trypsin inhibitor and alpha-lactalbumin.
TABLE a.1
Purification and Recovery of Protein
Total Protein Protein Recovered
Scheme Applied Recovered In ~CA Peak
mg mg a mg %
DEAE- Sepharose 1370 1300 95 91 7
G200 63 38 60 7-5 7
FPLC Mono Q 5.7 ND — 2. 3 li 0
FPLC Phenyl-Superose 2.3 ND — 0.5 22
CA = Fractions where conversion activity was detected. 
ND = Not Determined.
a .2.2 Analysis of Purified Conversion Factor
The results of fractionation of conversion activity 
by ion-exchange on DEAE-Sepharose, G200 gel-filtration, 
FPLC ion-exchange and FPLC hydrophobic interaction 
chromatography was a preparation containing a major* 
polypeptide of about 27kD, plus a l3kD component detected 
latterly in 12. 5% acrylamide gels under non-reducing 
conditions. In addition, there are small amounts of 
protein species in the 55-80RD range. This material was 
termed PSCA (for Phenyl-Superose derived Conversion 
Activity).
It was hoped that the components of PSCA could be 
analysed and identified using the commercially available 
antisera raised against many of the components of human 
serum. However, it first had to be demonstrated that the 
PSCA polypeptides were immunogenic. This was tested by 
using a multivalent antisera against whole human serum in 
Western blotting. In this experiment, the first antibody
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was rabbit anti-human serum diluted 1/100. The second 
antibody was 1/1000 peroxidase conjugated goat anti­
rabbit immumnoglobulin heavy chain. Peroxidase activity 
was detected by chloro-napthyl staining.
Figure l l.6 shows a Western blotting filter stained 
for protein to demonstrate transfer of protein from the 
SDS-PAGE gel onto the nitrocellulose. The 27kD band is 
too faint to be seen on the photograph but was present on 
the blot. Panels 2 and 3 were stained after application 
of the second antibody to detect peroxidase activity. 
Panel 2 is stained without application of the first 
antibody, and demonstrates that only the rabbit 
immunoglobulin heavy chain present in the rabbit serum 
track is stained. The third panel was stained following 
incubation with the first and second antibodies, and 
demonstrates that antibodies are present that bind a 
number of human proteins in serum (track 2), and that 
there is little binding to rabbit proteins (track l i )  . 
Track 3, containing PSCA, was heavily labelled in the 
region of albumin, demonstrating that the minor component 
of this mobility is a major antigen. Further staining is 
observed at a location corresponding to mobility of the 
27kD polypeptide, determined by comparison to the 
location of the 27kD band on the original SDS-PAGE.
Further controls in this experiment, namely chloro- 
napthyl incubation in the absence of second antibody both
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Figure U .6. Western Blot analysis of PSCA. Each of 
the three panels contains the following four tracks: 
molecular weight markers (Track 1), human serum (track 
2), PSCA (Track 3). and rabbit serum (Track 4). Panel 1 
shows a nitrocellulose panel stained for total protein. 
Panel 2 is a control for non-specific binding of second 
antibody. Panel 3 shows specific binding of antibody to 
protein components. Molecular weight markers were 
transferrin (37kD), albumin (66kD), ovalbumin (&5kD) , 
glyceraldehyde-3-phosphate dehydrogenase (36kD), carbonic 
anhydrase (29kD) and alpha-lactalbumin (l&kD).
before and after first antibody incubations, were 
negative and are not shown.
In order to conserve PSCA, it was decided to 
increase the ability to detect very small amounts of PSCA 
protein by labelling the material with radioactive iodine 
according to the Chloramine T protocol, and unlabelled 
human serum albumin was used as carrier protein.. This 
material was fractionated from the unbound counts by 
exclusion chromatography on Sephadex G15* The excluded 
material was resolved on a 15/° non-reducing SDS-PAGE and 
counts were detected by autoradiography (Figure l l. 7) • A 
number of clear bands of radioactivity were detected. 
Label running on the gel front was named Band 1, while 
material with mobilities corresponding to molecular 
weights of l8kD and 27kD were called Band 2 and 3 
respectively. In addition a smear was observed running 
from the top of the resolving gel down to a position 
corresponding to a molecular weight of approximately 
55kD. Alongside the non-reduced panel was run a single
track containing the same material resolved under
reducing conditions. The 27kD species is still present, 
while the l8kD species is resolved on 15% acrylamide as a 
species of lower molecular weight. Label is still
observed at the gel front, while the high molecular 
weight smear is resolved as a band with a molecular 
weight corresponding to albumin.
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Figure H .7■ Autoradiograph of iodinated purified 
rial (PSCA) run on a 15% acrylamide SDS-PAGE under 
reducing conditions. Areas of gel containing counts 
been arbitrarily assigned the numbers shown on the 
of the figure to ease description in the text. Shown 
the right of the main panel is a track of identical 
rial run under reducing conditions.
Gel fragments containing non-reduced Bands 1-3 were 
excised, as were four sections of the high molecular 
weight smear corresponding to 55-65KD (Band 4-), 65-75kD
(Band 5)* 75-85kD (Band 6), and 85kD and above (Band 7)-
Gel fragments were then electroeluted in dialysis tubing 
in an electric field of 200V. Elution proceeded for U 
hours and each hour the bags were opened and soluble 
counts measured. The results of this procedure are shown 
in Table H .2, in which the size of each band under 
reducing and non-reducing conditions are shown alongside 
the initial and final activity for each gel fragment, 
measured counts in solution every hour, and the resulting 
percentage recovered in solution after four hours. The 
table shows that as the polypeptide size increased, so 
the percentage recovery of activity declined, suggesting 
that larger proteins may have been trapped in the gel and 
would have benefited from a longer electroelution time. 
Also note that Band 1 soluble counts reached a peak very 
quickly, but fell off towards the end of the 
electroelution by as much as 30%, suggesting that counts 
were escaping through the dialysis bag.
TABLE 4.2
Electroelution of Gel Fragments
BAND MOLECULAR FRAGMENT_ACTIVITY SOLUBLE COUNTS % RECOVEI 
No. SIZE_kD INITIAL FINAL 1 2 3 A AFTER_4h
1 NR 430* 73 32 448 541 401 84,%
2 13 930 204 23 127 260 558 73%
3 27 890 196 11 240 352 666 77%
4 55-65 410 79 10 143 211 243 75%
5 65-75 630 390 3 99 166 246 39%
6 75-35 360 118 3 26 48 55 32%
7 >85 350 92 3 9 15 20 18%
NR = not resolved from dye front in 15% acrylamide.
* = all measurements of radioactive decay are presented
as counts per minute per lOOul of electro-elution
buffer.
Solutions containing more than 200 counts per second 
per lOOul (electroelution of Bands 1-5) were acetone 
precipitated to concentrate the counts in a smaller 
volume. The results are presented in Table 4.3. Band 1 
did not precipitate under the conditions employed, 
suggesting that it contained unbound counts.
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TABLE 4. 3
Acetone Precipitation of Soluble Counts
Band 1 2 3 ll 5
Pellet 
Supern'*' 
1st Wash 
Tube
2nd Wash 
Tube
mg
1323
2306
327
1548
537
1669
413
2463
159
854
972
1052
875
2857
67
1270
1203
250
855
279
ND
ND
ND
ND
ND
178
ND
ND
Recovery 
Activity pen 
Conc factor
ul
0% 33%
33ops
llx
65%
26cps
4x
94%
6 4cps 
19x
ND = not done
Concentrated aliquots of Bands 2-5 were run on a 15% 
SDS-PAGE under non-reducing conditions to assess the
quality and purity of the products (Figure 4.8). Band 2 
is seen at approximately l8kD molecular weight, Band 3 is 
between 27-29kD molecular weight, Band 4 contains two
species between 48 and 60kD, while band 5 shares the
higher molecular weight band at 60kD. There is no cross
contamination between the purified bands. Starting 
material is also shown and contains more intense counts 
in locations corresponding to the purified components.
The antigenic behaviour of PSCA and isolated Bands 
3-5 were analysed by antibody-antigen crossed 
electrophoresis (AACE), using whole human serum as both 
marker and carrier protein. Aliquots (0.08uCi) were 
placed in the sample well of AACE plates together with 
3ul of. human serum. After electrophoresis in the first
66 .
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Figure H .8. Autoradiograph of SDS-PAGE (17.5% 
acrylamide) on which was resolved iodinated PSCA (St), 
and concentrated iodinated bands 2, 3. & and 5 (as
indicated beneath the tracks). Tracks were run under non­
reducing conditions. Molecular weight calibration is 
shown to the left of the gel and comprised the following 
standard proteins: albumin, ovalbumin, glyceraldehyde-3~
phosphate dehydrogenase, carbonic anhydra.se, trypsinogen, 
trypsin inhibitor, and alpha-1actalbumin.
dimension, the second dimension gel was prepared 
containing 5% rabbit anti-whole human serum. Figures l l. 9 
to l l . 12 show the immunoprecipitation arcs of each AACE 
plate stained for protein, while the autoradiograph of 
the plate is shown inset and indicates the location of 
the labelled protein. Figure H .9 contains labelled PSCA, 
and 125j counts were detected in precipitation arcs 
corresponding to albumin, transferrin and alpha-mobility 
lipoprotein. Figure U . 10 contains labelled Band 3 (the 
27kD species), and label was detected with the expected 
mobility of alpha-lipoprotein, and more faintly in the 
albumin arc. The AACE plate containing labelled Band H 
(Figure Zl.ll) contained label in the albumin and alpha- 
mobility lipoprotein arcs, while the Band 5 plate (Figure 
l l . 12) was labelled in the albumin and transferrin arcs.
In each of the AACE plates containing isolated, 
homogeneous bands (as shown in Figure H . S ) there were a 
number of precipitation arcs containing small amounts of 
label. This suggested that there were some protein- 
protein associations which were not overcome by 
electrophoresis under the conditions used. This implies 
that only major arcs should be regarded as significant in 
drawing conclusions from these results.
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Figure U.9. AACE plate in which serum plus labelled 
PSCA was run against 5% anti-whole human serum in the 
second dimension. Inset is shown the autoradiograph of 
the plate indicating those arcs containing precipitated 
counts. Major labelled arcs are identified as albumin 
(A), alpha-1ipoprotein (L), and transferrin (T).
Figure U .10. AACE plate in 
isolated Band 3 was run against 
in the second dimension, 
autoradiograph of the plat 
containing precipitated counts 
identified as alpha-1ipoprote
which serum plus labelled 
5% anti-whole human serum 
Inset is shown the
e indicating those arcs
. The mao or labelled arc is 
in (L).
Figure H .11. AACE plate in which serum plus labelled 
isolated Band U was run against 5% anti-whole human serum 
in the second dimension. Inset is shown the 
autoradiograph of the plate indicating those arcs 
containing precipitated counts. Major labelled arcs are 
identified as albumin (A) and alpha-lipoprotein (L).
Figure U .12. AACE plate in which serum plus labelled 
isolated Band 5 was run against 5% anti-whole human serum 
in the second dimension. Inset is shown the 
autoradiograph of the plate indicating those arcs 
containing precipitated counts. Major labelled arcs are 
identified as albumin (A), alpha-lipoprotein (L) and 
transferrin (T).
£l. 2. 3 Identity of the l8kD Polypeptide Species
Evidence for the identity of the 27kD species as 
being a polypeptide component of alpha-lipoprotein has 
been documented above. It has been shown to have the 
expected molecular weight of apolipoprotein A-I under 
reducing and non-reducing conditions, and has been shown 
to precipitate in the alpha-lipoprotein arc in AACE. 
However, the identity of the iSkD species is less clear 
since it was only resolved in 12.5% acrylamide gels under 
non-reducing conditions, and since it was not isolated in 
sufficient amounts to be used in the AACE experiments. 
Thus, it was necessary to demonstrate that this low 
molecular weight component of PSCA had the mobility of 
apolipoprotein A-II under reducing and non-reducing 
conditions. PSCA was run in a 10% acrylamide gel 
containing.6M urea alongside purified apolipoprotein A-II 
(a gift of the Glasgow Royal Infirmary). The results 
(Figure .4.. 1 3 ) indicate that the mobility of the low 
molecular weight component of PSCA is indistinguishable 
from that of apolipoprotein A-II, and lend weight to the 
hypothesis that apolipoprotein A-II is indeed present in 
PSCA.
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Figure U .13. SDS-PAGE (10% acrylamide, 8M urea)
analysis of the low molecular weight component of PSCA. 
The gel was stained for protein. Tracks contain molecular 
weight markers (Mw), reference apo-lipoprotein A-II (A2), 
or purified conversion activity (PSCA). Tracks are run 
under reducing conditions (R) or non-reducing conditions 
(N) as indicated. Molecular weight calibration is shown 
to the left of the gel, and was generated from the
following standard proteins and peptides: carbonic
anhydrase (29kD), trypsin inhibitor (20kD), myoglobin
(17kD), plus peptides derived from specific cleavage of 
myoglobin with cyanogen bromide (l&kD, 3kD, 6kD, and
2kD ) .
l l . 2 . H Affinity Chromatography of Alpha-Li pop rote in
To summarise, PSCA contained proteins which, when 
labelled with ancj pUn on AACE together with whole
human serum, precipitate at the expected mobilities of 
albumin and alpha-lipoprotein and, to a smaller extent, 
transferrin. That the material fractionated on SDS-PAGE 
under reducing and non-reducing conditions, at the 
expected mobilities of transferrin and albumin supports 
the hypothesis that these species are indeed present. 
Furthermore, since alpha-lipoprotein is classically well 
known to be mainly comprised of the proteins apo­
lipoprotein A-I and A-II, having the molecular weights of 
28,500 and 17.500 respectively, it is possible that major 
components of PSCA are indeed those proteins. To test the 
hypothesis that a component of alpha-lipoprotein is 
responsible for conversion activity, rabbit antiserum 
specific to the apo-lipoproteins .of alpha-lipoprotein was 
conjugated onto a Sepharose IB column and used to remove 
apolipoproteins A-I and A-II from whole human serum by 
affinity chromatography. Whole human serum (1.5ml 
containing 63mg protein) was applied to the column in 
tris-succinate buffer containing 0.1M NaCl. Unbound 
protein was then collected in 1.0ml fractions. Bound 
protein was then eluted using 3•0M KSCN, and 1.0ml -
fractions were collected. Fractions were dialysed against 
tris-succinate buffer and the protein concentration
7H
estimated by optical density at 280nm.
Figure U . l U  shows a 12.5% SDS-PAGE on which has been 
resolved selected fractions from an affinity 
chromatography experiment. The 27kD band was absent from 
fractions 1-28 and was present in fractions 29-33. The 
material bound to the column and eluted with 3M KSCN 
contained a strong band at 27kD plus a minor species 
which ran close to the gel front. There was also some 
minor species in the molecular weight range 5 0 ,000-66,000 
daltons.
Equivalent amounts of protein from selected
fractions were applied into the sample wells of a 1- 
dimensional rocket immunoelectrophoresis plate and 
electrophoresed into an agarose bed containing a 1% 
concentration of the above antiserum. The relative
concentration of apolipoproteins in each fraction was 
then estimated by observing the height of the
precipitation rocket. This is shown in Figure 11.15, and 
confirms the SDS-PAGE analysis of the fractions, namely 
that flow-through of apolipoproteins (and saturation of 
the column) began in fraction 29. Bound protein eluted 
from the column was enriched in the apolipoproteins 
relative to the initial serum.
Fractions from the affinity chromatography were 
grouped into pools A, B and C. Pools A and B contained 
serum protein (adjusted to the original protein
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;ure b.lll. SDS-PAGE of selected fractions from ;ne
affinity chromatography of normal human serum on anti­
alpha lipoprotein-conjugated Sepharose k3. The gel was 
stained for protein. Tracks (labelled U) contain selected 
fractions of unbound protein (as numbered). Tracks 
(labelled 3) contain selected fractions of bound and 
eluted protein (as numbered). Molecular weight 
calibration is shown to the left of the gel, and was 
generated using the following standard proteins: 
transferrin, albumin, ovalbumin, glyceraldehyde-3- 
phosphate dehydrogenase, carbonic anhydrase, and trypsin 
inhibitor.
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Figure ll. 15. Rocket Immunoelectrophoresis plate 
(stained for protein) of selected affinity chromatography 
fractions in agarose containing 1% anti-alpha
lipoprotein. Tracks contain either whole serum (St), 
selected unbound fractions (as numbered, labelled "U") , 
or selected eluted fractions (as numbered, labelled "B"). 
All tracks contained 0.85mg protein.
concentration of the applied serum) which had passed 
through the affinity column unbound. Pool A was composed 
of early fractions (pre-fraction 29) which were depleted 
in apolipoproteins, while Pool B was composed of later 
fractions (post-fraction 29) which contained
apoliproteins. Pool C contained dialysed fractions of
serum proteins eluted from the column in 3M KSCN,
adjusted to the original volume used in the 
fractionation. These Pools were used to test whether
apolipoproteins were effective in the conversion of M- 
PLAP (Figure In this experiment, M-PLAP was
incubated with control tris-succinate buffer, control 
sera, and with affinity pools A, B and C. Negative 
controls of tris-succinate buffer with and without
incubation (tracks 1 and 2) indicated that PLAP substrate 
was predominately M-PLAP with some small contamination by 
- A-PLAP. The positive controls of reference serum with and 
without dilution and reconcentration (tracks 3 and l l )  
contain more A- and B-PLAP and less M-PLAP, and indicate 
the maximal extent of conversion under the conditions 
used. Tracks -5 and 6 contain M-PLAP incubated with Pool A 
and demonstrate that in the absence of apolipoproteins, 
no conversion is observed. Pool B, which was not depleted 
for apolipoproteins showed conversion activity (track 7). 
as did Pool C, which contained the desorbed 
apolipoproteins.
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In a separate experiment, serum was applied to the 
column in 0.5M NaCl, and the rest of the experiment 
repeated as described above. Although rocket
immunoelectrophoresis and PAGE gel analysis results were 
indistinguishable from the above, no conversion activity 
could be detected in any of the three pools. To test the 
hypothesis that the conversion activity was irreversibly 
inhibited by prolonged incubation in high salt buffers, 
serum was dialysed overnight into tris-succinate buffer 
containing either 0.1M or 0. 5M NaCl, followed by further 
overnight dialysis into tris-succinate buffer alone. 
Conversion activity was not subsequently detected in the 
serum dialysed into 0.5M NaCl, but was present in the 
positive control. This result led to the proposal that 
high salt concentrations can irreversibly inhibit 
conversion activity, and suggests that the conventional 
lipoprotein preparation method of salt density 
centrifugation may not be entirely appropriate for 
studies' of this kind.
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ti.3 DISCUSSION
a .3•1 Purification Strategy
The object of the present study was to purify and 
investigate the serum factor responsible for the in. vitro 
conversion of M-PLAP to A- and B-PLAP. The purification 
scheme was devised to separate the conversion factor from 
other serum components most efficiently. Following the 
ion-exchange chromatography (Figure a.l), fractions were 
selected to maximise the separation of conversion 
activity from the major protein species serum albumin, 
which had already been demonstrated not to be responsible 
for conversion activity (see Figures 2.2 and 2.3. where 
the presence of contaminating albumin did not convert M- 
PLAP to A- and B-PLAP).
Gel filtration was chosen for a second round of 
fractionation to demonstrate a previous undocumented 
observation ' that conversion activity had a molecular 
radius corresponding to a molecular weight of around 
60,000 daltons, and eluted from Sephadex G200 immediately 
after serum albumin. These observations were confirmed 
(Figure l l. 2) , and further fractionation of conversion 
activity was achieved.
Fast Protein Liquid Chromatography (FPLC) was used 
in the third round of fractdonation (Figure &.3). Protein 
species were found to elute from Mono Q at a higher salt
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concentration than they had eluted from DEAE-Sepharose. 
This was an unexpected effect, but was clearly not 
limited to conversion activity. This result indicates 
that, in general, elution on Mono Q cannot be predicted 
from the elution profile on DEAE-Sepharose.
A final step of hydrophobic interaction
chromatography on FPLC was chosen on the basis that, 
since conversion activity has an affinity for the 
relatively hydrophobic M-PLAP, it was possible that 
conversion activity would be retained on the Phenyl- 
Superose column under conditions in which protein 
contaminants would not. Conversion activity was detected 
within the the final protein peak observed eluting from 
the column (Figure 4.5)•
4.3.2 Components of the Purified Species
The final purified conversion activity (PSCA) was 
found to be composed largely of a single polypeptide 
species of around 27kD molecular weight, together with a 
smaller species resolved in 15% SDS-PAGE having a 
molecular weight of around 8,000 daltons under reducing 
conditions (and 18,000 in native gels), plus minor 
species in the molecular weight region of 55-80,000 
daltons.
Several lines of evidence point to the 27kD 
polypeptide being apolipoprotein A-I. Firstly, the
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polypeptide has a molecular weight and mobility close to 
that already reported for apolipoprotein A-I under 
reducing and non-reducing conditions (Baker ejt al, 197^-; 
Brewer et_ ai, 1 9 7 8). Secondly, the 27kD species co­
precipitates in the precipitin arc of alpha-mobility 
lipoprotein in AACE (Figure Thirdly, column
affinity chromatography with anti-alpha-lipoprotein 
specifically binds conversion activity and a 27kD 
polypeptide.
Less strenuous evidence has been provided for the 
nature of the 8,000 /  18,000 dalton species. In part, 
this was due to the unfortunate choice of 10% SDS-PAGE 
during the purification of conversion activity, 
preventing this low molecular weight species from being 
resolved. Immunological characterisation of this species 
was prevented by the low yield of the labelled band.
Nevertheless, it has been shown that the low molecular 
weight species is indistinguishable from apolipoprotein 
A —II on SDS-PAGE under reducing and non-reducing 
conditions (Figure l l . 13).
The high molecular weight, low abundance material 
resolved at 55-80,000 daltons has been shown to be 
located in the albumin and transferrin precipitin arcs in 
AACE (Figure l l . 11 and l l . 12), and are not considered to be 
responsible for conversion activity (see argument above).
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fl-,3-3 Size Considerations of Conversion Activity
The major polypeptide species co-purifying with 
conversion activity are apolipoproteins A-I and A-II. 
These species are normally associated in a complex 
lipoprotein array of high density lipoproteins (HDL), 
which gel filters in the region of 200,000 molecular 
weight. Gel filtration of serum indicates that no 
conversion activity is detected in that molecular weight 
range, and purified HDL has no conversion -activity 
(Chapter 2). Thus, the apo A-I and A-II species 
implicated in conversion cannot be associated with HDL. 
This activity of a small population of apo A-I and A-II 
molecules may represent the known heterogeneity amongst 
lipoprotein polypeptides (Nestruck et a_l, 1980), or be 
simply due to steric hindrance in those polypeptides 
already associated with lipid.
4.3.4 Lipoprotein Function in Conversion
The results presented in this chapter have shown 
that conversion activity can be irreversibly abolished by 
prolonged incubation in 0.5M NaCl. This suggests that the 
routine preparation of apolipoproteins by salt density 
centrifugation may be inappropriate in functional studies 
of apo A-I and apo A-II. This may help to explain why no 
functions have been reported for apolipoproteins which 
suggest a role in M-PLAP conversion. Apo A-I is a known
activator- of lecithin-cholesterol acyl transferase 
(LCAT), though no conversion of M-PLAP was evident on 
incubation with a purified sample of LCAT (Chapter 2).
The products of M-PLAP conversion are.not uniform, 
but consist of two products, A- and B-PLAP. This suggests 
that there must be molecular heterogeneity within M-PLAP 
and/or the conversion factor functions in two mutually 
exclusive ways. Recent evidence bearing on both the 
structure of M-PLAP and on the nature of the conversion 
activity will be discussed in the following general 
discussion.
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CHAPTER 5
GENERAL DISCUSSION
CHAPTER 5.
GENERAL DISCUSSION
5.1 Three Classes of Membrane Binding Proteins
Since M-PLAP is associated with lipid in the
microvillous membrane (Abu-Hasan et al, 1984-), it is of
interest to review the general mechanisms by which 
protein-lipid association is thought to take place. All 
lipid-associated polypeptides known to date can be 
classified as having an hydrophobic anchorage, or
covalently bound to fatty acid via thioester and/or amide 
bonds, or covalently associated with a complex glycolipid 
via phosphodiester linkage.
The first class of membrane proteins is
characterised by the presence, in the mature polypeptide, 
of sequences of hydrophobic amino acids which anchor the 
protein in the membrane (Capaldi, 1 9 8 2). These amino 
acids are in some cases located at one or other terminus 
of the protein, while in other cases the polypeptide 
chain is believed to traverse the membrane with 
substantial domains on both sides of the bilayer.
Another common form of anchorage is widespread in 
viruses, bacteria, and eukaryotes, in which fatty acids 
are covalently bound to cysteine side chains via 
thioester bonds or to the amino-terminal residue by amide 
linkage (Magee and Courtneidge, 1 9 8 5 ). The former linkage
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involves the most abundant acyl chains i.e. palmitate, 
stearate, and oleate, while amide linkage is exclusively 
to myristate. Most of these proteins are membrane bound 
as might be expected for proteins modified with a 
hydrophobic acyl chain. However, a number of myristylated 
proteins fractionate in the cytosol fraction. Recent 
reports of Rous sarcoma virus transforming protein pp60 
suggest that amino-terminal myristylation is required, 
but not sufficient, for the plasma-membrane localisation 
of the protein (Cross et al, 1984; Buss e_t al_, 1984). 
Thus some myristyl proteins may be able to move between 
the cytosol and cell membranes, perhaps after a 
conformational change involving exposure of the acyl 
chain. Alternatively, myristylation may have a role in 
the interactions of one protein with another or with a 
substrate.
By contrast, a number of eukaryotic proteins are 
currently believed to be covalently bound to fatty acids 
as components of complex glycosyl-inositol phospholipids, 
and the diacylglycerol moiety of phosphatidylinositol has 
been shown to be the sole means of membrane attachment 
(Low ejfc al,1986; Cross, 1 9 8 7). In general, inositol 
proteins have been identified by their specific and non- 
disruptive release from the cell membrane by 
phosphatidylinositol-specific phospholipase C. However, 
details of the chemistry and synthesis of the hydrophobic
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linkage have been gleaned from studies of a few well 
characterised inositol proteins.
5.1.1 Trypanosome Variant Surface Glycoproteins
The parasitic protozoan Trypanosoma brucei is 
protected from the host immune system by the sequential 
expression of genes encoding immunologically distinct 
variant surface glycoprotein (VSG), which form a dense, 
protective surface coat (Cross, 1984; Turner, 1984). In 
viable trypanosomes, the VSGs are firmly anchored to the 
plasma membrane; upon lysis, by either mechanical shear 
or osmotic shock, the VSG coat is rapidly released in a 
water-soluble form (sVSG). Amino acid sequencing of this 
form has revealed that sVSG lacks a C-terminal 
hydrophobic peptide extension of 17 or 23 amino acids 
(depending on the variant), predicted from cDNA 
sequences. The mode of membrane attachment of mature VSG 
remained unclear until work by Cardoso de Almeida and 
Turner (1983) revealed that lysis of trypanosomes in 
boiling detergent solutions resulted in the recovery of 
an amphiphilic membrane form of  the VSG (mfVSG). The 
conversion of mfVSG to sVSG was shown to be due to an 
endogenous phospholipase C and to correlate with the 
presence or absence of myristic acid (Ferguson et al, 
1984; Ferguson and Cross, 1984). Further analysis 
revealed that the C-terminal glycolipid also contained
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ethanolamine (Holder, 1933a), phosphate (Balts et al, 
1982; Cardoso de Almeida and Turner, 198/i), sugars 
(Holder and Cross, 198I; Holder, 1983b), and glycerol 
(Duvillier et al , 198 3).
Purification and analysis of the myristylated 
pronase fragment of mfVSG has revealed that the myristic 
acid is covalently attached to the glycan in the form of 
s ,n-1,2-dimyristyl glycerol, via a phosphodiester linkage 
(Ferguson e_t al, 1935a, b).
5.1.2 Other Pi-Linked Membrane Proteins
Consistent with the evidence for VSG precursor 
polypeptide tails, the DNA sequence of the rodent Thy-1 
antigen predicts a thirty-one amino acid tail that is 
absent from the mature protein (Seki et al, 1985). and
can be released from the membrane by a highly purified 
phosphatidylinositol-specific phospholipase C (Low and 
Kincade, 1935)•
The chicken neural cell adhesion molecules (N-CAMs) 
represent an intriguing situation: two forms of N-CAM are
typical transraembrane proteins with different cytoplasmic 
domains, but a third is Pi-linked (He et a l , 1 9 8 6 ). All
three polypeptides are derived from transcripts of a 
single gene by alternative RNA splicing (Hemperly et al, 
1936). It remains to be established whether addition of 
PI is associated with cleavage of its predicted
86
hydrophobic terminal amino acid sequence.
5.1.3 Structural Features of Pl-Protein Anchoring Domains
Although the structural features of other 
hydrophobic membrane anchoring domains in other proteins 
have not been characterised in as much detail as VSG, 
certain features seem to be shared. In
acetylcholinesterase (Dutta-Choudhury and Rosenberry, 
1934-) and Thy-1 (Tse e_t al, 1935) these domains are
located at the carboxy-terminus. Rat brain Thy-1, thymus 
Thy-1 and erythrocyte acetylcholinesterase (AChE) have 
been shown to contain relatively few amino acids, none of 
which are hydrophobic. Thy-1 membrane anchoring domain 
contains ethanolamine, glucosamine, myo-inositol and 
fatty acids. The membrane anchoring domain of erythrocyte 
AChE also contains glucosamine, ethanolamine and fatty 
acids, but interpretation is complicated by the 
observation that only a small proportion of the AChE in 
human erythrocytes is released by PI-PLC (Low and Finean, 
1977; Shukla and Hanahan, 1932). In view of these unusual 
shared structural features, it seems likely that these 
other proteins are also linked to PI by a structure 
similar to that identified for ’ VSG. A pictorial 
representation of the predicted carboxy-terminal 
membrane-binding domain of phosphatidylinositolated 
(glypiated) proteins is shown in Figure 5.1.
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Figure 5•1« Proposed general structure of the C- 
terminal membrane anchoring domain of a PI-PLC sensitive 
protein. The structure is based on the evidence available 
for VSG of trypanosomes. It is likely that other 
phosphatidylinositolated proteins are bound by a similar 
structure, although the actual composition and
arrangement of the sugars in the glycan is likely to be 
variable. Figure from Low et al (19-36).
Conceivably, any eukaryotic membrane protein that 
terminates in a short hydrophobic segment is a candidate 
for glypiation. While there is yet no identifiable 
consensus sequence for glypiation, such a signal may 
become evident as more Pi-linked proteins are added to 
the repertoire of predicted protein sequences.
5.1.4- Functional Signlficance of Covalently Attached PI
The evidence that the diacylglycerol moiety of PI is 
solely responsible for membrane anchoring in AChE, VSG 
and Thy-1 is very strong and is based on three principle
lines of evidence. Firstly, there is an absence of any
substantial hydrophobic amino acid sequence in the
membrane anchoring domain isolated from mature VSG
(Cross, 198&), Thy-1 (Tse et_ al, 1985)* or human
erythrocyte AChE (Roberts and Rosenberry, 1985)- 
Secondly, there is non-disruptive release of these
proteins from the plasma membranes to which they are 
attached, and/or conversion from an amphiphilic form to a 
non-aggregating hydrophilic form (Ferguson et a l , 1985b).
Thirdly, membrane bound VSG can be converted to a water
soluble form by an endogenous phospholipase (Ferguson et 
al, 1985a).
The fact that an apparently adequate, hydrophobic, 
membrane-anchoring peptide is removed from the carboxyl 
terminus of VSG immediately after synthesis suggests that
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covalently attached lipid may, in general, serve some 
other purpose in addition to membrane attachment. It may 
relate to the intracellular transport and targetting of 
the polypeptide from the endoplasmic reticulum to the 
outer surface of the plasma membrane. The fact that all 
proteins currently believed to be covalently attached to 
phosphatidylinositol are also predominantly located on 
the outer surface of the plasma membrane seems to support 
this suggestion. Alternatively, it may provide a means of 
selectively mobilising, in. viv o , proteins so anchored. 
Glypiation, in combination with specific PI-PLCs, permits 
rapid and specific release of membrane-bound enzymes or 
receptors, thus generating soluble activities or down- 
regulating receptors. Again, it may be significant that 
diacylglycerol, an activator of protein kinase C, is a 
product of the protein-releasing reaction. Signaling 
specificity could be introduced if individual members of 
the protein kinase C family displayed differing 
sensitivities to diacylglycerols having different acyl 
groups. The possibility that diacylglycerols can be 
converted in the inner plasma membrane leaflet to 
phosphatidic acid introduces another putative regulatory 
mechanism (Moolenaar et al, 1986).
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5.2 Membrane Anchorage in Alkaline Phosphatases
Slein and Logan (1962; 1 9 6 3 ) reported that a factor-
present in Bacillus cereus culture filtrates, when 
injected in rabbits, produced a large increase in serum 
alkaline phosphatase activity, and also released alkaline 
phosphatase from kidney and bone slices. The factor later 
turned out to be a phosphatidylinositol-specific
phospholipase C, suggesting that tissue-unspecific 
alkaline phosphatase was bound to the membrane via
interactions with a phosphatidylinositol molecule (Slein 
and Logan, 1965; Low and Finean, 1977). Since this 
tissue-unspecific alkaline phosphatase was released in a 
soluble non-aggregating form which was not associated 
with membrane vesicles nor with other lipid-protein 
complexes, and by analogy with other
phosphatidylinositolated proteins, it was believed that 
PI was specifically involved in the attachment of these 
proteins to the membrane, and that 1,2-diacylglycerol was 
serving as a membrane anchor which was largely or 
entirely responsible for membrane attachment. Further
analysis suggested that the association between tissue- 
unspecific alkaline phosphatase and phosphatidylinositol 
was a covalent one (Low and Zilversmit, 1980).
The mechanism of membrane binding of mammalian 
intestinal alkaline phosphatase is less clear. Seetharam 
et al (1937), found that rat intestinal brush border
alkaline phosphatase was not released from the brush 
border membranes by phosphatidylinositol-specific 
phospholipase C. Further studies led to the proposal that 
rat intestinal alkaline phosphatase was bound to the 
membrane by tight hydrophobic interactions rather that a 
covalent association. However, conflicting work by Low et 
al (198 7) showed that treatment of bovine intestinal 
alkaline phosphatase with nitrous acid resulted in 
release of the enzyme in a soluble form and free myo­
inositol, suggesting that the protein contained a 
phosphatidyl moiety attached through a glycosidic linkage 
to a sugar residue bearing a free amino group.
5.2.1 Models of Membrane Binding of Placental AP
Since the work described in this thesis was 
concluded there have been a number of published reports 
from the Udenfriend group which together strongly 
indicate the mechanism of membrane binding in placental 
alkaline phosphatase.
Berger ejt al (1987b), working on simian (COS) cells 
transfected with a eukaryotic expression vector (pBC12) 
bearing a cDNA encoding human placental alkaline 
phosphatase, found that the cells transiently expressed 
membrane-bound alkaline phosphatase. The enzyme could be 
specifically released from the cell surface in a 
hydrophilic form by treatment with phosphatidylinositol-
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specific phospholipase C, a property strongly indicative 
of the presence of an inositol-glycan membrane anchor. 
Furthermore, the transiently expressed alkaline
phosphatase was heat-stable and resistant to inhibition 
with 1-homoarginine but sensitive to inhibition with 1- 
phenylalanine, and thus had properties characteristic of 
the PLAP isoenzyme. A criticism of this work, however, is 
that . the monkey cell line does not normally express 
placental alkaline phosphatase, and therefore the post- 
translational glypiation of the enzyme may not reflect 
the situation in the human trophoblast.
In parallel with this work, Howard ejt al (1987) 
characterised the alkaline phosphatase expressed in WISH, 
a transformed cell line from human amnion. When cell 
suspensions were incubated with purified
phosphatidylinositol-specific phospholipase C, alkaline 
phosphatase activity was released in a hydrophilic form. 
Also, when the cell were cultured in the presence of 
[l^C] ethanolamine, [lilC]myristic acid, or myo-
[3h ]inositol, each was incorporated into the carboxyl 
terminus of the alkaline phosphatase. The alkaline 
phosphatase expressed in the WISH cell line was reported 
as heat-stable, resistant to catalytic inhibition by 1- 
homoarginine and susceptible to inhibition by 1- 
phenylalanine. This led the workers to the belief that 
they were studying placental alkaline phosphatase.
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However*, precise identity had not been established 
between this placental-like alkaline phosphatase 
expressed by transformed cells, and tissue-extracted 
placental alkaline phosphatase (see the introductory 
chapter of this thesis for a general review of this 
subject)..
Although the above reports are limited in the extent 
to which the results can be seen as models of the 
mechanism of membrane binding of normal trophoblast 
expression of placental alkaline phosphatase, they 
complement each other and together suggest that placental 
alkaline phosphatase may be covalently associated with 
glycolipid. However, to further examine this possibility 
it is important to study placental alkaline phosphatase 
as extracted from the placenta. -
5.2.2 Membrane Attachment in Tissue-Extracted PLAP
Evidence for the mechanism of membrane attachment of 
tissue-extracted placental alkaline phosphatase came from 
the Udenfriend group as this thesis was being prepared 
for submission. Micanovic et al (1988) purified and 
characterised the C-terminal chymotryptic polypeptide 
from a commercial preparation of PLAP. Their
investigation revealed that the carboxy-terminal amino 
acid residue of mature PLAP is an aspartic acid residue, 
to which is attached a phosphatidylinositol-glycan
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moiety. The aspartic acid residue was demonstrated to be 
Asp-484., suggesting, by analogy to VSG protein 
processing, that a 29-residue polypeptide predicted from 
the cDNA sequence is cleaved out during glypiation. 
Consistent with other examples of inositolated proteins, 
this cleaved polypeptide is highly hydrophobic and may be 
involved in anchoring the nascent polypeptide to the
endoplasmic reticulum prior to inositolisation.
The results of Micanovic et al (1988) were derived
from study of only those PLAP molecules demonstrated to 
be hydrophobic by their behaviour in Triton X-114 phase- 
separation. The remaining 90% of the PLAP molecules were 
found to be hydrophilic in behaviour, indicating to the
workers that the diacylglycerol portion of the
phosphatidylinositol-glycan had been lost during
preparation of the enzyme. An alternative interpretation, 
that is not raised in their report, is that the
hydrophilic PLAP is not a degradation product, and thus 
that the commercial preparation corresponds to the 
condition of PLAP in. vivo. This interpretation reflects 
the findings of the Sutcliffe group, in that our
preparations of PLAP contain A-PLAP, B-PLAP and M-PLAP. 
However, no attempt was made by Micanovic et al (1988), 
nor by any of the Udenfriend group, to
electrophoretically characterise the PLAP molecules. The 
question therefore remains open as to whether M-PLAP is
9 &
inositolated and whether removal of this "converts” M- 
PLAP to A-PLAP.
Conversion of PLAP from a hydrophobic to a 
hydrophilic form has also been investigated by Malik and 
Low (198 6), who have been particularly interested in 
the possible conversion in vivo. They have approached 
this study by attempting to characterise the necessary 
conditions for hydrolysis, firstly on butanol extraction 
and secondly in normal human plasma.
5.2.3 Butanol Extraction of Placental AP
Malik and Low (1986) have suggested that 
solubilisation of human placental alkaline phosphatase by 
butanol involved the activation and action of an 
endogenous factor. On extraction of placental membranes 
at pH 5*4-. the alkaline phosphatase released into the 
aqueous phase was found to be indistinguishable from that 
released on incubation with a phosphatidylinositol-
specific phospholipase C from Staphylococcus aureus i.e. 
both forms were relatively hydrophilic and had molecular 
radii of around 170,000. By contrast, butanol extraction 
at pH 8 .3 . or at low pH in the absence of calcium ions, 
released an aggregated form of approximately 600,000 
molecular size which was relatively hydrophobic.
Proteinase inhibitors had no effect. Further
investigation of the effect indicated that the
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phosphoinositide-specific phospholipases C from cytosol 
and lysosomes were unlikely to be responsible for 
conversion. Malik and Low (1 98 6 ) also detected a 
phosphatidylinositol-hydrolysing activity in the 
particulate fraction. However, under conditions in which 
the Pl-hydrolysing activity was completely abolished, 
PLAP-conversion activity was unaffected. Characterisation 
of this factor in the absence of butanol, lipids and 
enzymes was not attempted.
The above report provides a close parallel to the 
work described in this thesis, and hence deserves closer 
examination and comparison with this work. At no stage of 
the present work, or of the work of Abu-Hasan (thesis), 
was the pH of butanol extraction controlled or measured, 
except that it was performed in a low-buffered solution 
of pH 7-0 (namely 25mM succinic acid, 4mM Tris). The 
relative quantities of M - , A- and B-PLAP recovered were 
variable, however, and seemed to be dependent on the 
efficiency of washing of the microvillous membrane 
pellet. This uncontrolled observation is consistent with 
both the leeching out of the Malik and Low factor prior 
to extraction, and with the removal of the conversion 
factor examined in this thesis.
It is important to note that this butanol-stimulated 
conversion . phenomenon need not have occurred in our 
hands, since Malik and Low prepared their placental
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membranes from whole homogenised placenta as contrasted 
with our enriched microvillous membranes, a difference 
which is likely to alter the co-purifying contaminants.
It must also be stressed, that any such conversion 
during butanol extraction was effectively invisible to 
the Sutcliffe group, since we disregarded, to a large 
extent, the relative proportions of A- and M-PLAP with a 
view to fractionating the isoenzymes by chromatography.
The conversion phenomenon reported by the Sutcliffe 
group is of the butanol extracted products, which were 
stable in the absence of serum, and was not calcium 
dependent. It may be the case, therefore, that there are 
two independent mechanisms of conversion.
5.2.4 Conversion of PLAP Isoenzymes in Plasma
As this thesis was being prepared for submission, a 
report was published by Low and Prasad (19S8) describing 
an activity abundant in mammalian plasma which removed 
the phosphatidylinositol membrane anchor from hydrophobic 
human placental alkaline phosphatase. The activity could 
be inhibited by EGTA and 1,10-phenanthroline, and was 
stimulated at low pH. The workers suggested that the 
agent responsible for the activity was the same as that 
described by Malik and Low (1 9 8 6 ), and proposed that the 
presence of the activity in the Malik and Low particulate 
fraction was due to contamination by the plasma enzyme.
The specificity of the agent was examined and the results 
indicated that conversion was due to a phospholipase D 
activity.
5.3 Conversion and Apolipoproteins
Part of the present work was the discovery of a 
factor present in normal human serum that mediated 
conversion of hydrophobic, membrane-bound M-PLAP to the 
soluble forms A- and B-PLAP following butanol extraction. 
This conversion is not affected by the addition of 
antiproteases, and does not involve loss of subunit size 
detectable on SDS-PAGE. This, together with the evidence 
of Abu-Hasan, Davies and Sutcliffe (1984) that M-PLAP 
remained hydrophobic on incubation with a range of 
organic solvents and ionic and non-ionic detergents, 
implies that M-PLAP is tightly associated with a 
hydrophobic moiety. The above work of Micanovic et al 
(1 9 8 8) indicates that commercially available hydrophobic 
PLAP is covalently associated with a phosphatidylinositol 
glycan moiety. It is likely, though not proven, that the 
hydrophobic PLAP characterised by Micanovic et al is 
at least very similar to the hydrophobic PLAP studied In 
this thesis, namely M-PLAP. Work by Low and Prasad (1988) 
has shown that normal plasma contains a phospholipase D 
activity which cleaves the phosphatidylinositol tail from 
hydrophobic PLAP ir vitro, although purification and
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identification of the factor has not yet been reported. 
The present work has purified and characterised the M- 
PLAP converting activity from normal human serum, and it 
has been demonstrated as associated with lipoprotein A.
5.3.1 Functions of Lipoproteins and their Components
The study of lipoproteins and apolipoproteins has 
essentially focused on a number of inter-related areas. 
Plasma lipoproteins have attracted the attention of 
investigators interested mainly in lipid transport (for 
reviews see Morrisett e_t al, 1975; Scanu et al, 1982), 
both in the normal condition, and in relation to diseases 
e.g. atherosclerosis (Goldstein and Brown, 1977), 
coronary thromboses, alcoholism, Tangier Disease. 
Other workers have, however, focused on the fact that 
plasma lipoproteins participate in the activation or 
inhibition of lipid-metabolising enzymes. For example, 
apolipoprotein A-I is a specific activator of lecithin 
cholesterol acyl transferase (Yokoyama ejt al, 1 9 7 8 ; 
Furukawa and Nishida, 1979), and apolipoprotein C-II 
enhances the triglyceridase and phospholipase A^ activity 
of rat heart lipoprotein lipase (Groot et a l , 197 8). The
mechanism of action of these apolipoproteins is not fully 
understood, but appears to involve enhancement of the 
transfer of the enzyme between vesicles (Nishida et a l . 
1 9 8 6). It has also been shown that plasma lipoproteins
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play important roles in lymphocyte proliferation and 
immunologic homeostasis (Morse et al, 1977; Chisari, 
1977)- Thus, it is becoming increasingly evident that 
circulating lipoproteins are dynamic structures and
recognise a series of structural changes which are 
controlled by enzymatic and physicochemical phenomena.
Most recently, lipoprotein vesicles have been 
demonstrated to be crucial in a number of cellular- 
activities, including release of cell surface proteins 
from tissue explants. LDL binding to plasma membrane 
receptors appears to suppress cholesterol synthesis 
through modulation of the activity of 3-hydroxy-3- 
methylglutaryl coenzyme A reductase (Goldstein and Brown, 
1977). Further, the apolipoproteins of high density 
lipoprotein (HDL), namely apoA-I, apoA-II and apoC-I, 
have been shown to stimulate the release of human 
placental lactogen (hPL) by placental explants 
(Handwerger et al, 19S7 ). Other recent work by Darbon. et
al (19S6 ) demonstrated that HDL apolipoproteins- 
stimulated phosphorylation of a 27kD protein in quiescent 
bovine endothelial cells, strongly supporting a role for 
apolipoproteins in stimulating protein kinase C.
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5«3.2 Lipoproteins or Apolipoproteins in PLAP Conversion
Despite intensive and extensive research into the 
roles played by lipoproteins and their protein
components, there appear to have been no reports of any 
directly induced changes in other proteins caused by 
apolipoproteins. More specifically, given the hypothesis 
that M-PLAP is covalently bound to phosphatidylinositol, 
there have been no reports of a phospholipase activity
directly associated with apolipoproteins or lipoproteins. 
A recent (17/11/87) computer literature search on Data-
Star (copyright Biological Abstracts, Inc.,
Philadelphia/Penn, USA) searching for English-language 
reports on lipoproteins or apolipoproteins in association 
with phospholipases and in association with plasma, serum 
or blood published between 1985 and 1987 revealed no 
relevant reports. This leaves the author to consider a 
number of possible hypotheses. As raised in the 
discussion of the relevant chapter, it is likely that the 
conversion activity is associated with apolipoproteins A- 
I and A-II. However, this association may be direct, in 
the form of a previously undiscovered activity of the 
apolipoproteins, or indirect by means of other protein 
factors. These possibilities are discussed in more detail 
below.
The action of a factor associated with lipoprotein A 
on M-PLAP could be due to an as yet undetected activity
of the apolipoproteins 
conversion factor. This 
due to the routine 
lipoproteins i.e. salt 
herein reports that 0.5M NaCl 
removed the conversion activity, 
first appear to be unlikely 
structure of apolipoprotein
analyses of Segrest et al 
(1977) and of Fitch 
secondary structure of 
least 11 alpha-helical 
cycles of 11 repeating 
does not take into
microheterogeneity of 
the level of primary
function. A subset,
apolipoprotein A-I^, 
atypical properties 
LCAT, and may contain 
(Nestruck et al; 1980). 
small percentage of 
activity.
A second hypothesis to 
conversion activity upon the 
associated factor is that the
purified 
"hidden” 
of serum 
The work 
irreversibly 
might at 
secondary 
to the 
and Feldman 
A-I has a 
having at 
, and 13 
reasoning 
degree of 
both at 
level of 
namely 
shown to have 
activation of 
acid sequence 
possible that a 
M-PLAP conversion
explain the dependence of 
presence of a lipoprotein- 
apolipoproteins activate an
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comprising 95% of the 
activity has remained 
method of isolation 
density centrifugation, 
completely and
This hypothesis 
given the predicted 
A-I. According
 (197&). Segrest
(1977) apolipoprotein 
limited complexity, 
regions, two beta-sheets 
units. However, this 
account the high 
apolipoprotein molecules, 
structure and at the 
of apoA-I molecules, 
have already been 
with respect to the 
a different amino 
It is therefore 
apoA-I contains
endogenous phospholipase. This phospholipase may be 
present as a minor species of the purified conversion 
activity (PSCA), or as a contaminant of the butanol- 
extracted microvilli used as the source of M-PLAP. Given 
the range of chromatography systems employed in the 
fractionation of serum to give PSCA, any phospholipase 
activity co-purifying with apoA-I is also associated with 
apoA-I either in the phospholipid vesicles or in 
apolipoprotein aggregates or the apolipoprotein in free 
solution. This hypothesis is thus indistinguishable from 
the previous hypothesis of the direct action of the 
apolipoproteins, and has again never been observed by 
other workers. That the phospholipase activity originates 
in the M-PLAP substrate is also unlikely since purified 
M-PLAP, which contained two PLAP bands' plus albumin, was 
a good substrate for conversion with normal human serum.
5 . & Summing Up
This project was aimed at the elucidation of the 
differences between the A-, B- and M-PLAP forms, and at 
the nature of the serum conversion activity. The recent 
reports of Low and Prasad (1988) and of Micanovic et al 
(1988) indicate that mammalian placental alkaline 
phosphatase contains a covalently attached
phosphatidylinositol-glycan at its carboxy-terminus, and 
that this can be cleaved from the molecule in. vitro by a
103
phosphatidylinositol-specific phospholipase D activity 
abundant in normal mammalian plasma. It is likely that 
the hydrophobic PLAP molecules found by these workers is 
partly or wholly analogous to the hydrophobic PLAP
described in this thesis and by Abu-Hasan (thesis). It 
follows therefore that there is a likelihood that at 
least M-PLAP contains an inositol anchor, and that A-PLAP 
does not contain the anchor. The nature of B-PLAP is less 
clear. In order to determine the substrate/product 
relationships between the phospholipase D activity and 
the isoenzymes of PLAP, the experiments of Micanovic need 
to be repeated demonstrating the relative proportions of 
A - , B- and M-PLAP.
This thesis has described the purification and
characterisation of a factor present in normal human 
serum that mediates the conversion of M-PLAP to A- and B-
PLAP. The activity has been shown to be associated with
apolipoproteins A-I and A-II. Whether this conversion 
phnomenon is similar to that described by Low and Prasad 
(1 9 8 8) remains to be demonstrated, but the possibility 
has been raised that apolipoproteins may have other 
functions and activities other than those already 
characterised and associated with lipid metabolism. 
Purification of apolipoproteins by more gentle methods 
than salt density centrifugation may reveal the nature of 
these activities.
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CHAPTER 6
GENERAL METHODS
CHAPTER 6_ 
GENERAL METHODS
6.1 Preparation of Plaoental Alkaline Phosphatase
6.1.1 Purification of Placental Microvilli
Placental microvilli were prepared according to the 
method of Smith et al (1974), as described by Abu-Hasan 
et al (1934), as follows:
1) Fresh placentae (less than 4 hours old) were given
an initial wash in 0.85% saline and 1.22% CaCl.
2) Amnion and chorionic plate disected off, and
remaining material chopped into pieces of approximately 
lcm3 .
3) Material washed in 150-l80ml ice-cold saline for 30
mins at 4°C with rapid and continuous agitation.
4) The w&sh was then poured off and spun at 12,OOOg for 
10 mins at 4°C in a Beckman JA-14 (13cm radius). The
supernatant was taken and subjected to
ultracentrifugation at 145,OOOg in a Beckman Ti50 rotor 
(7cm radius) for 30 mins at 4°C.
5) If the resulting pellet was still red, then the
pellet was resuspended using a tight fitting glass 
homogeniser in Tris-succinate buffer (25 mM succinic 
acid, 4 mM Tris, pH 7.0) and ultracentrifugation step
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repeated. Once the pellet was creamy-white, it was 
resuspended and stored at -20°C, until a stock of 
phenotyped placentae had built up.
6.1.2 Butanol Extraction of Microvilli
Syncytiotrophoblast plasma membrane preparations 
were extracted using the method of Boyer (1 9 6 3 ).
1) To each suspension of microvillous membranes was 
added an equal volume of ice cold butan-l-ol, and the 
mixture shaken vigourously for 1 hour at 4°C.
2) The mixture was subjected to centrifugation at 
12,OOOg for 10 mins at 4°C, to separate the aqueous 
and organic phases.
3) The aqueous phase (bottom) was drawn off and 
dialysed against Tris-succinate buffer (pH 7.0) overnight 
to remove excess butanol.
6.2 Electrophoresis
6.2.1 Starch Gel Electrophoresis
Horizontal starch gel electrophoresis was performed 
at pH 6.0 (Robson and Harris, 196 5 ) as previously 
described (Abu-Hasan et al_, 1984).
1) 25s starch was suspended in 290 ml Tris-succinate
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buffer (pH 6.0), and heated to boiling point with rapid 
agitation to keep the starch in suspension until 
dissolved.
2) Approximately 1.25ml Triton X-100 (0.5%) was added 
to 10ml Tris-succinate buffer (pH 6.0), and the mixture 
heated to dissolve the detergent.
3) Both mixtures were added together and swirled to 
mix.
U ) Before the starch had begun to set, the solution
was poured into a perspex former. A thin plastic sheet 
was added as a lid, taking care to exclude air bubbles,
and this was topped by a heavy glass plate to expel
excess starch solution. This was then placed at h ° C for 
one hour for the starch to set.
5) Once cold, the glass plate and the plastic sheet
were removed, and the detergent-starch block was cut
lengthwise twice, once 1cm from a long edge, and once 5cm 
further up - and parallel to the first cut. The 1cm wide 
piece of gel was removed from the perspex former and 
kept aside. The 5cm wide slice was then slid down,
revealing a cut surface within the body of the gel onto 
which 5mm x 7mm fragments of 3MM blotting paper were 
applied, impregnated with 20ul of PLAP solution. These 
fragments were inserted upright onto the cut surface of 
the starch block, alternating with inserts wetted with 
Tris-succinate buffer alone. Once complete, the gel was
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reclosed by sliding the gel up and replacing the 1cm
slice.
6) The block was then placed in an electrophoresis
tank containing 0.&1M citric acid, pH 6.0. Paper wicks 
were applied, ensuring that the sample papers were 
towards the cathode, and 8v/cm was applied for 5 hours at 
4°C.
7) After this time, the block was removed from the
perspex former and cut horizontally to reveal a
representative cro.ss-section of the gel.
S) This was stained using a solution of Fast Blue RR
salts (25mg) and beta-napthyl phosphate (25mg) in 50ml 
borate buffer (60mM sodium tetraborate, lOmM MgSOjj.. 7H 2O , 
pH 9.7).
6.2.2 Acrylamide Gel Electrophoresis
SDS—PAGE was performed by the method of Laemmli
(1970), modified to run slab gels. Gels were routinely 
made up to 10% acrylamide, although 12.5%, 15% and 17.5%
gels have been used.
1) Glass plates were washed in acetone and 100%
ethanol, and and 2mm spacers washed in ethanol alone.
The plates were assembled and made watertight with tape.
2) The acrylamide stock solution was 30% acrylamide,
0.8% bisacrylamide.
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3) Stock resolving gel buffer comprised 3.OM Tris-HCl
(pH 8.9).
h ) Stock stacking gel buffer comprised 0.5M Tris-HCl
(pH 6.7).
5) Stock detergent solution was 10% SDS.
5) 1.5% ammonium sulphate solution was made up fresh
daily.
6)(i). For a 10% gel, 15ml acrylamide was added to 5.6ml 
resolving gel buffer, 0.3ml SDS, 21.7ml dH20, and 1.5ml 
persulphate.
(ii) For a 12.5% gel, 18.75ml acrylamide was added to 
5.6ml resolving gel buffer, 0.3ml SDS, 18ml dH2O f and
1.5ml persulphate.
(iii) For a 15% gel, 22.5ml acrylamide was added to 
5.6ml resolving gel buffer, 0.3ml SDS, - 14.2ml d ^ O ,  and
I.5ml persulphate.
7) 25ul TEMED was added to the appropriate mixture,
and quickly poured between the glass plates, leaving room
to add the stacking gel.
8) Since air inhibits the polymerisation of
acrylamide, the solution was overlayed with 0.1% SDS or
butanol.
9) 5% stacking gel solution was made up by adding
2.5ml acrylamide to 5.0ml stacking gel buffer, 0.2ml SDS,
II.3ml dH20, and 1.0ml persulphate.
10) When the resolving gel had polymerised, the gel
109
plates were wrapped in cellophane and stored at 4°C for 
up to 48 hours until ready for use. Stacking gel was not 
formed on top of the resolving gel until within 2 hours 
of running the gel, in order to maintain the pH step at 
the gel interface.
11) The top of the gel was washed with a small ' volume 
of the stacking gel solution. 15ul TEMED added to the 
remaining solution and the gel plates filled to the top. 
The gel comb was inserted which would form the wells, 
making sure that no air bubbles were left, and the gel 
left to polymerise.
12) Meanwhile, double concentration sample buffer was 
made up containing 0.12M Tris-HCl (pH 6.8), 20% glycerol, 
4% SDS, 0.004% bromophenol blue. To the reducing sample 
buffer was added 10% beta-mercaptoethanol.
13) 10-50ul of sample containing l-10ug protein per 
protein species was added to an equal volume of sample 
buffer in 0.5ml eppendorf tubes. Reduced samples were 
boiled for 3mins in steam, while non-reduced samples were 
kept on ice. Finally the samples were subjected to 
microcentrifugation to collect all the solution at the 
bottom of the eppendorf tubes.
14) In addition to the sample tracks, marker proteins 
were included in the gel in order to calibrate the gel. 
Typical proteins included ovalbumin (45,000), bovine 
serum albumin (66,000), transferrin (87,000) and beta-
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galactosidase (116,000).
15) Electrophoresis buffer was made up to contain 
0.025M Tris-HCl (pH 8.3), 0.192M glycine, 0.1% SDS. 16)
The gel comb and bottom tape were removed and the gel 
wells washed quickly in dilute stacking buffer before
assembly into the electrophoresis tank. Samples were 
loaded in appropriate wells and gently overlayed with 
electrophoresis buffer. The tank was then filled with 
electrophoresis buffer and 40mA applied for approximately 
4 hours, or until the bromophenol blue front had reached 
the bottom of the gel.
17) Following electrophoresis, the gel was carefully 
removed from the gel plates and submerged in 10% acetic 
acid, 30% methanol, 0.3% Coomassie brilliant blue for 
approximately 1 hour. The gel was then destained in 10%
acetic acid, 30% methanol until the protein bands showed
blue against a clear background. The gels were either
photographed immediately, stored in 10% acetic acid, or 
washed for T hour in 30% ethanol, 1% glycerol and dried 
down under vacuum.
6.2.3 2-D Antibody-Antigen Crossed Electrophoresis
Antibody antigen crossed electrophoresis was 
performed as described below.
1) Glass plates measuring 9cmx9cmx2mm were used
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throughout, and were pre-coated as follows. 10ml of 
molten 1% agarose dissolved in distilled H20 was poured 
onto and spread evenly over each plate. Plates were left
to cool at room temperature. The plates were then
incubated at 37°C until dry, leaving an agarose film on
the surface. This film helped in anchoring the agarose
gel to the glass plate.
2) .Barbitone buffer was made up with 58mM (12g per 
litre) 5.5T-diethylbarbituric acid, sodium salt, 24mM 
(4.4g per litre) 5,5T-diethylbarbituric acid, pH 8.6. 
At this stage, 0.2g thiomersal as preservative was added 
per litre buffer.
3) 1% agarose in barbitone buffer was melted and 15ml
poured onto and spread evenly over each plate, avoiding 
air bubbles, and left to cool. The remaining agarose was 
kept at 50°C in a water bath, as were a number of cut tip
10ml pipettes and test tubes.
4) A well was punched in a corner of each plate using
the cut tip of a pasteur pipette, such that the 2mm
diameter hole was 1.5cm from one edge and at least lcm
from the other edge.
5) The sample, normally 4ul containing approximately 
150ug normal serum proteins, was loaded into the wells 
with a Hamilton syringe, as was lul of 0.01% bromophenol 
blue as a front marker.
6) The plate was subjected to electrophoresis at 20mA
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at 4°C in barbitone buffer, such that the antigen 
migrated parallel to the edge of the plate.
7) Examination of the migration of the bromophenol 
blue revealed two spots of differing mobilities. This was 
interpreted as bromophenol blue-bound albumin lagging 
unbound bromophenol blue.
8) When the albumin was judged to have migrated to
about 1cm from the far edge of the plate, electrophoresis 
was stopped, and the plates removed to room temperature.
9) A cut was made across each plate 2mm from, and
exactly parallel to, the track of the sample. Further 
cuts were made from this line at 1cm from the edge 
following the perimeter of three sides, thus forming a 
rectangle in the middle of the plate. This rectangle of 
gel was carefully excised, and the glass plate underneath 
cleaned with a tissue.
10> 6ml of 1% agarose in barbitone buffer cooled to 
50°C was transferred to a warmed test tube using a warmed 
cut tip pipette. To this was added antibody to a. known 
final concentration, usually 5% rabbit anti-whole human 
serum, and the mixture vortexed.
11) Before the agarose began to set the 6ml was
transferred onto the rectangular well avoiding air 
bubbles, and spread evenly within the well.
12) Once cool, electrophoresis was performed at right 
angles to the first dimension at 5mA at 4°C overnight,
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such that the sample migrated into the antibody bed.
13) Following .electrophoresis, the plates were 
submerged in physiological saline. The plates were gently 
agitated at room temperature for at least 48 hours with 
at least 3x1 litre changes of saline, thus allowing the 
unprecipitated sample and antibody remaining in the gel 
to leach out during this time.
14) . The gel was then overlayed by a square of blotting 
paper cut to size, and incubated at 37°C until completely 
dry.
15) The plates were then stained with coomassie blue 
stain as described for acrylamide gels.
6.2.4 Rocket Immunoelectrophoresis
Rocket immunoelectrophoresis was performed as 2- 
dimensional AACE with the exception that electrophoresis 
was performed only in one dimension directly into the 
antibody bed.
6♦3 Assay Systems
6.3.1 Estimation of Protein Using Folin Reagent
Protein assay was carried out according to the 
method of Lowry et al (1951), with the modification of 
Bonsall and Hunt (1971) for solutions containing Triton 
X-100.
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1) A standard solution of lmg/ml bovine serum albumin 
was made up in the same buffer as the unknown sample, and 
was used to provide a range of protein amounts, all in 
200ul. The unknown sample was diluted over a broad range, 
and 200ul taken at a number of dilutions.
2) Solution A was made up as 2% Na-jCO^ in 0.1M NaOH.
3) .Solution B contained 1% CuS0^.5H20
4) Solution C was 2% KNa tartrate.
5) Solution D was made up as 25ml solution A, 250ul 
solution B and 250ul solution C.
6) 1ml solution D was added to 200ul of each standard 
and diluted sample. Each tube was immediately vortexed, 
and left to stand at room temperature for 10 minutes.
7) To each reaction was added lOOul of freshly 50% 
diluted folin ciocalteu’s phenol. Reactions were vortexed 
again, and left to stand at room temperature for a 
further 40 minutes. For samples containing Triton X-100, 
the phenol solution is diluted in a final concentration 
of 0.25% SDS.
8) Optical densities were measured at 500 nanometres,
and a graph drawn of the protein standards. The
concentration of the unknown sample was interpolated from 
the graph.
6.3.2 Protein Estimation By Optical Density
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A rough estimation of protein concentration can be 
quickly gauged by measuring optical densities as detailed 
below.
1) A range of sample dilutions were made in dH20.
2) Optical density measured in 1cm quarts cuvettes
at 260nm, 280nm and 320nm, using dH20 as a blank.
3) . The 320nm reading was subtracted from the 260nm and 
280nm readings.
4) The ratio of the 280/260 readings was calculated.
If the ratio was greater than 1.4, as it was in most 
cases, then the corrected 280nm reading was assumed to be 
approximately equal to the protein concentration. Below
1.4, this assay method is increasingly inaccurate and
another protein assay system was employed.
6.3.3 Alkaline Phosphatase Assay
Alkaline phosphatase activity was measured using 
the method of Sutcliffe et al (1972), with p-
nitrophenolphosphate as substrate.
1) Substrate solution was made up containing 20mg/ml 
p-nitrophenolphosphate in 6mM MgCl2 , 31mM Na^jCO^, pH 
10. 7-
2) 30ul substrate solution was added to a range of 
alkaline phosphatase dilutions, all in 20ul.
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3) This mixture was left at room temperature for 30 
minutes with frequent vortexing.
4) Enzyme activity stopped by the addition of 1ml stop 
buffer (0.05M glycine, 50mM EDTA, 50mM potassium 
phosphate, pH 9-3).
5) Optical density was measured at 400nm, and the 
alkaline phosphatase activity calculated, given the 
extinction coefficient of 1.,62x10^.
6.4 Column Chromatography
Details of the protocols used for gel filtration, 
ion-exchange and FPLC chromatography are given in the 
relevant results sections.
6.4.1 Activation of Sepharose 4B
Some experiments used commercially activated 
Sepharose, though on some occasions we used Sepharose 
that had been activated in the laboratory. Activation was 
performed as described by Porath et al (1958) and as 
follows:
N .B . CNBr is hazardous, as under acidic conditions can 
give off HCN fumes, and should therefore be handled in a 
fume cabinet. All materials coming in contact with CNBr 
should either be washed immediately afterwards, or 
protected with foil.
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1) On the basis that lg wet weight Sepharose can bind
15mg protein, the required amount of matrix is weighed 
out. lOg wet weight Sepharose requires Ig CNBr for
activation and a total reaction volume of 25ml.
2) Sepharose 4B slurry weighed out and poured into a 
clean, dry column. This is washed well with 2-3 column 
volumes of distilled H20.
3) Solid CNBr very carefully weighed out and dissolved 
in 1/3 total reaction volume of dH20.
4) A pH probe was placed in the CNBr solution to
monitor pH for remainder of reaction. A peristaltic pump 
was primed with 2M NaOH, with outlet over the CNBr
beaker.
5) Slowly, the washed Sepharose was added. Sufficient 
NaOH was pumped into the beaker to maintain pH above
11.3.
6) High pH maintained for at least 10 minutes, or
until pH stabilised.
7) Once equilibrated, the Sepharose was poured back
into the column and washed with ice-cold dH2O t then cold
0.1M NaHCOg (at least 4-5 column volumes).
8) Solutions eluting from the column were drained 
into a beaker containing 10M NaOH to neutralise any 
remaining CNBr.
9) The Sepharose was now ready to be incubated with the
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protein to be bound.
6.4.2 Antibody Coupling to CNBr-Activated Sepharose 4B
Antibody coupling to CNBr-activated Sepharose 4B was 
performed as recommended by Pharmacia as follows:
1) The required amount of Sepharose was weighed out, 
allowing lg per lOmg bound protein.
2) The Sepharose was well washed in ImM HCL on a
sintered glass funnel under vacuum, using at least 200ml 
HCl per gram matrix.
3) Antiserum was diluted in coupling buffer (0.1M
NaHCOg, 0.5M NaCl, pH 8.3). allowing 5ml per gram
Sepharose. Sepharose added and the vessel stoppered. 
Mixed well for two hours at room temperature.
4) Excess ligand was washed away with- coupling buffer
and.assayed for protein concentration. Difference between 
total soluble protein before and after coupling indicates 
amount of protein bound on matrix.
5) Remaining active sites were blocked by incubating
with ethanolamine (1M, pH 9.0) for two hours at room
temperature. Product was then washed with three cycles of
acetate buffer (0.1M, 0.5M NaCl, pH 4.0) followed by Tris
buffer (0.1M, 0.5M NaCl, pH 8.0).
6) Product poured into column and stored in Tris-
succinate buffer (pH 7.^ ) containing 0.1M NaCl.
119
6.4.3 Antibody Affinity Chromatography
Many variations in the conditions used for antibody 
affinity chromatography were used, including
concentrations of NaCl in application buffer, presence or 
absence of ammonium hydroxide, and either sodium 
phosphate or Tris-succinate buffers. What follows are the 
details of those parameters under which the control 
experiments worked.
1) The column used contained 346mg of rabbit antiserum 
raised against human alpha-lipoprotein bound to 35ml 
Sepharose 4B.
2) 1.5ml of normal human serum at a protein 
concentration of 42 mg/ml was applied onto the column in 
ice-cold Tris-succinate buffer containing 0.1M NaCl at a 
flowrate of 75ml/hour. Unbound protein was collected in 
1.0ml fractions which were assayed for protein by optical 
density.
3) Protein bound to the column was eluted using 3.0M 
potassium thiocyanate, and 1.0ml fractions were 
collected.
4) Selected fractions of unbound protein were pooled, 
desalted and reconcentrated by ultrafiltration, to a- 
final concentration of 42mg/ml, and assayed for 
conversion activity. Selected fractions of bound protein
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were desalted and reconcentrated to a final concentration 
approximating to the concentration of this protein in the 
starting serum. This was calculated by firstly expressing 
the total bound protein as a fraction of the total 
recovered protein, which approximates to the proportion 
of associating protein present in the applied serum, as 
well as to the starting concentration of such protein.
5) Selected fractions were also analysed on 1- 
dimensional rocket electrophoresis and on SDS-PAGE.
6) The column was re-equilibrated with Tris-succinate 
buffer containing 0.1M NaCl, and stored at 4°C until 
required.
6.5 Miscellaneous Techniques
6.5.1 Western Blotting
Western blotting was carried out as described 
below. Initial transfer of protein from the gel onto the 
nitrocellulose sheet was performed according to the 
method of Towbin el: aJL (1979). Antibody probing utilised 
the modern technique of using 0.1% Tween to prevent non­
specific association of antibody to the nitrocellulose.
1) SDS-polyacrylamide gels were run as described
above, with tracks arranged to give 6 identical panels 
divided by one blank track.
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2) One panel was removed for Coomassie blue staining 
as above, while the remaining gel was washed in transfer 
buffer (25mM Tris base, 192mM glycine,. 20% methanol) .
3) Nitrocellulose was cut to the dimensions of the
remaining gel and washed in transfer buffer, as were four 
pieces of blotting paper the size of the plastic former.
4) Taking care to exclude air bubbles, a sandwich was
made up of the former, two sheets of blotting paper, the 
gel, the nitrocellulose, more blotting paper, and finally 
the plastic former.
5) The sandwich was transferred to the transfer tank
such that the gel was more towards the cathode than was
the nitrocellulose. The tank is filled up, again avoiding 
the inclusion of air bubbles.
6) Transfer was performed at 200mA overnight with
cooling and mixing of the transfer buffer.
7) Following transfer, the sandwich was dismantled and 
the gel stained with Coomassie blue and compared with the 
untransferred panel to check transfer out of the gel. The 
nitrocellulose was washed in TBS-tween (lOmM Tris-HCl, pH 
7-4, l40mM NaCl, 0.1% Tween 20) to remove any adhering 
polyacrylamide.
8) To check transfer onto the nitrocellulose, one
panel was- cut from the nitrocellulose and stained with 
0.1% amido black in 45% methanol, 10% acetic acid for 10 
minutes, and destained with 45% methanol, 10% acetic
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acid.
9) The remaining four panels, were then separated, and 
treated differently as follows.
10) The experimental panel was washed in the first
antibody diluted in HST buffer (lOmM Tris-HCl, 1M NaCl, 
0.5% Tween 20) for one hour with constant shaking. The
correct dilution factor for the antibody was assessed per 
se, with the expectation that it was between 1:100 and
1:1000. The polyspecific antibody used in this work was
diluted to a. final concentration of 1:400. The correct 
volume of solution to use depends upon the size of the
panel, and is calculated as 1ml per 10cm2 of
nitrocellulose.
11) The panel was then removed and washed at room 
temperature in TBS-tween. After five minutes, this 
solution was poured off and replaced with fresh TBS-tween 
and. washed for a further five minutes. The filter was 
then washed in HST, then a further twice in TBS-tween.
12) The peroxidase-conjugated second antibody was
applied diluted 1:500 - 1:1000 in HST buffer, and the
filter washed for a further hour at room temperature with
constant shaking.
13) The filter was removed and washed three times in 
TBS-tween, once in HST, followed by three times in TBS- 
tween. Finally, the filter was washed in TBS.
14) Substrate solution was made up by dissolving l8mg 4-
123
chloro-l-napthol substrate in 5ml methanol. This was 
added to 9lnil TBS and 25ul H 20 2 immediately before use. 
Substrate solution was poured onto the nitrocellulose
panel and agitated for approximately 30mins, or until the 
panel was stained. The panel was kept in distilled water 
in the dark at 1°C.
15) The other three panels acted as controls and were 
all stained with /l-chloro-l-napthol following incubation 
with either first antibody alone, or second antibody 
alone, or with no antibody.
6.5 » 2 Radiolabelling of Protein
Proteins were radiolabelled with by the
Chloramine T method of Greenwood et al (1963), using the 
modifications of Hunter (1970).
1) Phosphate buffer made up containing 0.05M sodium 
phosphate, pH 8.0, and used to make up the following
reagents:
3% bovine serum albumin as carrier protein
dissolved in phosphate buffer containing 0.02% sodium
azide.
0.5mg/ml Chloramine T dissolved in 25ul phosphate 
buffer.
0.5mg/rnl sodium metabisulphate.
1 mCi Na125j dissolved in phosphate buffer.
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2) Purified protein to be labelled present in
phosphate buffer at a concentration of 0.05mg/ml in 20ul.
3) Added lmCi of 125i, followed by 25ul of Chloramine
T solution, and mixed.
1) After 60 seconds, added 50ul of metabisulphate
solution, and the solution was diluted with 1ml of BSA- 
phosphate.
5) .Free iodide was removed by passing solution down a 
column packed with Sepharose G-15 equilibrated with BSA- 
phosphate, collecting the unretarded fraction.
6) The resulting preparation was stored at 1°C and
used within 1 weeks.
6.5.3 Preparation of Normal Human Serum
1) Fresh blood was taken and left to stand at room 
temperature for half an hour.
2) Blood then placed at 1°C overnight.
3) Spun in a swing bucket rotor (Beckman SW 7.5) at 
900rpm for 5 minutes at 1°C.
1) Supernatant poured off and dialysed overnight in
Tris-succinate buffer, pH 7.1. Frozen down and stored in 
aliquots.
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